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1 
GENERAL INTRODUCTION 
Introduction 
Organic synthesis is one of the most challenging fields of organic chemistry. The 
ultimate goal of the synthetic natural product chemist is to synthesize by the most efficient 
route complex molecules that are either natural products themselves or exhibit similar 
biological activity. Often a compound that contains an active part of a natural product may 
exhibit similar activity. This dissertation will show application of new methodology 
developed by us to construct skeletons and active fragments of several classes of natural 
products. 
The dissertation is divided into three chapters. The first shows two strategically 
different approaches to the sjmthesis of pyrrolobenzodiazepines. The second covers 
preparation of phenanthrenequinones and their application as useful intermediates for the 
construction of angularly-fused aromatic compounds. The third chapter demonstrates a new 
way of constructing the quaternary center contained in morphine and similar alkaloids using 
a Lewis acid-mediated cyclization of an acyl quinone. 
Dissertation Organization 
This dissertation was written so that each chapter represents a publishable article. 
The numbering scheme adopted for the compounds and the references is independent for 
each paper. Following the last chapter is a general conclusions section which highlights the 
research results. 
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CHAPTER 1. SYNTHETIC APPROACHES TO 
PYRROLOBENZODIAZEPINES 
A paper, a portion of which was submitted to Tetrahedron 
George A. Kraus and Alex Melekhov 
Introduction 
General 
Pyrrolo[2,l-c][l,4]benzodia2epines (PBDs) are anti-tumor agents produced by 
Streptomyces bacteria. The PBD ring system (1) (Scheme 1) is also found in a group of 
naturally-occurring DNA-interactive anti-tumor antibiotics known as "anthramycins". 
Scheme 1 
The PBDs differ in the number, type and position of substituents in both the benzene 
ring A and pyrrole ring C. The most well known members of this family include 
tomaymycin (2), chicamycin A (3) and DC-81 (4) (Scheme 2). 
All naturally occurring compounds possess the (S)-configuration at CI la. This 
provides an appropriate shape to fit within the minor grove of DNA. Once inserted, an 
aminal bond is formed between guanine and CI 1 (Scheme 3). The structure of this adduct is 
confirmed by several studies.' Measurement of DNA-binding activity of a series of PBDs 
H 
O 
1 
3 
demonstrated a correlation between DNA-binding activity and cytotoxicity in some cell 
lines." 
Scheme 2 
MeO 
H ^OMe 
Tomaymycin (2) 
MeO 
H ^^OMe 
Chicamycin A (3) 
MeO 
DC-81 (4) 
Scheme 3 
H2N. 
.Guanine-DNA 
Depending on the structure of the compound, method of isolation and solvent, PBDs 
exist as carbinolamine (7), imine (8) or carbinolamine ether (9) forms (Scheme 4). However, 
the imine appears to be the actual reactive species. 
Scheme 4 
H PMe 
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Previous synthetic approaches 
There are several major routes to pyrrolo[2,l-c][l,4]-benzodiazepines that have been 
reviewed several years ago.^ Besides summarizing the existing approaches, this report also 
describes several potentially interesting synthetic directions. 
One of the first reported"* methods for the synthesis of PBDs involves reduction of 
dilactam pyrrolo[2,I-c][1.4]-benzodiazepine-5,l 1-diones (10) (Scheme 5). 
Scheme 5 
^BHVMeOH 
LAHmHF/-W®C 
H PMe 
In general, reduction of amides or lactams with hydride-donating reducing agents can 
lead to a number of different products depending on the structure of the substrate, the type of 
the reducing agent and the reaction conditions. The most challenging task here is to avoid 
overreduction that may lead to ring-opened primary amino alcohols. Electron-withdrawing 
groups in the aromatic ring enhance stability of the NlO-Cll carbinolamine form and 
provide efficient reduction; however, they are not present in the naturally occurring PBDs 
and lack biological activity. The partial reduction problem remains one of the most 
interesting topics in PBD chemistry, since several methods are available for the synthesis of 
dilactams in high yield. 
Dilactams are usually prepared by three different ways that all utilize a proline 
derivative as an enantiomerically pure source of ring C. Proline esters and amides along with 
prolinol are all commercially available or can be prepared from proline in a minimal number 
of steps. 
Cyclization of iV-(2-nitrobenzoyl)pyrrolidine-2-carboxylic acid or esters (11) 
prepared by coupling of the corresponding 2-nitrobenzoyl chlorides (12) and prolines or 
proline esters proceeds upon catalytic hydrogenation (Pd-C/H2) either under acidic or basic 
conditions and provides pyrrolo[2,l-c][1.4]-ben2odiazepine-5,ll-diones usually in good 
yield^ (Scheme 6). This method was used in the synthesis of chicamycin A (3), anthramycin 
and some other members of the PBD family.^ 
Scheme 6 
a 
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Another method employed^ is based on the cyclocondensation of isatoic anhydrides 
(13) with substimted prolines (14) (Scheme 7). Early descriptions involved pyridine as a 
solvent. However, later use of DMF or DMSO provided higher yields, especially in the case 
of substimted substrates. 
Scheme 7 
13 
COORi 
HN^ 
Pyridine or 
DMSO or DMF 
14 
This route was applied in the synthesis of tilivalline and several anthraraycin type 
molecules.® However, it requires initial preparation of substituted isatoic anhydrides that 
often reduce the overall yield. 
One other approach developed in recent years^ is based on the use of the palladium 
catalyzed carbonylation of a bromoaryl substituted proline amide (15) to prepare dilactam 10 
(Scheme 8). In this route, Cll-N bond is formed first and then the Pd-mediated 
carbonylation-cyclization under elevated CO pressure results in the desired ring system. 
Unfortunately the yields of this reaction are generally poor and it's especially ineffective 
when substituted prolines become amino acid components. 
Scheme 8 
15 
Pd(OAc)2/PPh3 
BU3N, CO (high 
pressure), A 
R4r 
An alternative to the partial reduction of the dilactam with hydrides (Scheme 5) that 
often results in mixtures another general and mild method was developed in the early 
eighties.® Treatment of the parent dilactam 10 with P2S5 in refluxing benzene afforded NIO-
C11 monothiolactam 16, which upon treatment with triethyloxonium tetrafluoroborate gave 
imino thioether 17 in high yield. Its reduction with an excess of freshly prepared Al-Hg 
amalgam in aqueous THF afforded a thiocarbinoiamine, which in turn was converted to the 
desired imine 8 by passing through a silica gel column (Scheme 9). Reduction-elimination, 
however, proceeded in low yield and the product was accompanied by a signiHcant amount 
of saturated secondary amine 18. Besides the low yield at the reduction stage, this method 
suffers the necessity of freshly prepared amalgam for optimal results and produces 
difficulties with separation of the products. 
Scheme 9 
R-H-
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18 
One of ±e most straightforward methods used in the construction of PBDs is the 
cyclization of substituted N-benzoylpyrrolidine precursors. The reductive cyclization of N-
(2-nitrobenzoyl)-pyrrolidine-2-carboxaldehydes (19) is very difficult to stop at the stage of 
the imine. The application of poisoned catalysts, such as Pd/BaS04, along with frequent 
TLC or GC monitoring in some cases afforded partially reduced product in moderate yield' 
(Scheme 10). However, in most cases, the saturated amine 18 is the major product. 
Attempts to optimize yields established that the type and amount of catalyst, the volume of 
solvent and the reaction time are all critical. Results varied depending on the freshness of the 
catalyst and chromatographic separation of the imine was not always possible. In general, 
this method, despite its experimental simplicity, lacks reproducibility. 
8 
The cyclization of A/-(2-aminobenzoyI)pyrrolidine-2-carboxaldehyde dialkyl acetals 
20 is based on in situ fonnation of amino aldehyde intermediate 21 that can spontaneously 
cyclize to PBD irnine'" (Scheme 11). However, one of the major disadvantages of this 
method is that deprotection of the acetal can lead to racemization at the CI la position, 
particularly under acidic conditions. 
Scheme 11 
OEt |_OE, 
20 
HT or Rjr 
TMSI 
8 
To overcome this limitation the use of a thioacetal protecting group, instead of an 
acetal, was devised." Protection of the nitroaldehyde 19, followed by reduction with tin 
dichloride furnished cyclization precursor 23 (Scheme 12). The mild cleavage conditions 
(HgCli/CaCOs, acetonitrile-water) afforded good yields of imine 8 with cyclization taking 
place with both substituted and unsubstimted aromatic rings whereas other methods often fail 
in one or the other case. Also, the stereochemistry of the aldehyde-bearing carbon was 
preserved during thioacetal fonnation and subsequent deprotection. 
9 
Scheme 12 
CHO EtSH pJL 
TMSCI 
DJ \_>R CHCI3 
19 
IVIeOH 8 
Results and Discussion 
PIFA oxidation approach 
Our initial studies were directed to oxidation of the secondary amine 18. It was 
reported earlier that this approach despite its attractiveness has not been signiHcantly 
explored. 
Scheme 13 
O O 
18 8 
Attempted oxidation with MnOo resulted in formation of fiilly unsaturated systems.'" 
A very recent report'^ described the oxidation with tetrapropylammonium pemithenate and 
A/-methyImorpholine iV-oxide that proceeded in 40% yield. 
To begin our investigation, we needed an efficient method of preparation of large 
quantities of amine 18. Our initial attempts to reproduce early results'^ ran into several 
10 
problems. Despite an efficient formation of amide 25 from 5-methoxysalicylic acid and 
prolinol in the presence of DCC, the following tosylation with TsCI and pyridine yielded 
chloride 26 as a major product (Scheme 14). 
Scheme 14 
OH H OH p r;n„nH QH Q 
Jv^COOH ^'VCHaOH 
V 
OMe 
24 
DOC 
87% 
To overcome this problem, the phenolic OH was first converted into a triflate with 
PhNTfi, forming triflate alcohol 27, and then tosylated to give the desired tosyl triflate 28 in 
67overall yield (Scheme 15). Unfortunately, all attempts to cyclize this intermediate to the 
cyclic amine 29 upon treatment with NH3 even at an elevated temperature and pressure 
failed. 
Scheme 15 
OTT O 
TsCI 
OMe 67% 
MeO 
O OMe 
27 28 29 
To investigate the potential problem of this initial substitution of the tosyl group with 
ammonia, we decided to first prepare and isolate amine triflate 30. The triflate tosylate 28 
was converted to azide 31 upon reacting with NaNs in acetonitrile and then reduced with 
11 
triphenylphosphine in the presence of water to furnish 30 in 88% yield over two steps 
(Scheme 16). However, this amine also did not undergo cyclization upon treatment with 
various bases (EtsN, DBU, LDA, BuLi). 
Scheme 16 
OTf O CH2N3 OTT O CH2NH2 
- S: (YO -5  ^ -
88% 
Interestingly, treatment of 30 with LiTMP in THF at -78°C to room temperature 
produced in low yield (<30%) an interesting cyclophane 32 (Scheme 17). Its formation may 
be explained by initial ortho-metalation, formation of a benzyne intermediate, and 
regioselective nucleophilic attack at the meta position. Again, no desired 29 were formed. 
Scheme 17 
LiTMP 
30 — 
PH2NHU CH2NHLi 
We ultimately identified a workable synthesis of cyclic amine 29 from 5-methoxy-2-
nitrobenzoic acid (33) by adapting and improving chemistry originally reported by Thurston 
and coworkers.'^ This route involved formation of amide 34, prepared in 94% yield from 
prolinol, DCC, A/-hydroxybenzotriazole (BTOH) and A^-methylmorphoIine (NMM) (Scheme 
12 
18). Dess-Martin oxidation'® of the resulting alcohol provided the aldehyde 35 in 83% yield. 
Both procedures proved to be more reliable and convenient then those reported.'^ Finally, 
reductive hydrogenation in the presence of 10% Pd-C catalyst in methanol afforded 29 in 
77% yield. 
Scheme 18 
NO2 NO2 O CH2OH NO2 O QHQ 
Proiinol, Dess-Martin Hg/Pd-C 
V 
OMe 
33 
DCC 83% EtOH 
94% 
29 
At this point we were able to prepare gram quantities of the cyclic amine by this 
route. Our first plan was to demethylate this compound and then oxidize it to an 
iminoquinone, expecting the latter to rearrange, forming a hydroxy-substituted PBD (Scheme 
19). Unfortunately, all attempts to cleave the methyl group resulted in recovery of amine 29. 
Treatment with TMSI, BBra, NaCN/DMSO at 160°C or BuSLi/HMPA all proved 
unsuccessful, either giving back the starting material or unidentified decomposition products. 
Scheme 19 
Demethylation 
29 
HO HO 
O O 
As a second possibility, we attempted to AT-chlorinate the secondary amine and then 
treat it with base, forcing elimination (Scheme 20). However, chlorination mostly proceeded 
13 
in the electron-rich aromatic ring to form ortho chloride 36 and iV-chloro amine 37 which 
was isolated as a minor product which decomposed upon treatment with DBU. Since N-
chlorination was not efficient, we did not develop this approach further. 
Scheme 20 
t-BuOCI 
29 
MeO 
O 
36 (major) 
O 
37 (minor) 
DBU 
-7^- inmne 
Then we transferred our attention to direct oxidation of tricyclic amine 29 (Scheme 
21). First studies showed its stability to a number of oxidants. Silver (I) oxide, AgO/HNOs, 
CAN and DDQ failed to provide the desired imine. 
Scheme 21 
MeO 
AgO/HNO 3 
or DDQ 
or CAN 
29 and/or 
decomposition 
products 
Finally, we decided to apply recently developed oxidants based on the 
polycoordinated iodine.'^ Both [bis(trifluoroacetoxy)]iodobenzene (PIFA, 38) and 
diacetoxyiodobenzene (39) have proven to be clean and efficient reagents of choice in a 
number of difficult cases of aromatic oxidation'® (Scheme 22). 
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Scheme 22 
I(0C0CF3)2 OH O 
MeCH 
90% 
PIFA 
38 OEt MeO OEt 
I(0C0CH3)2 OH O 
39 NHCOPh 
CF3CH2OH 
PIFA 
N Ph 
To our delight, application of both reagents resulted in the desired oxidation, although 
in moderate yield in initial runs. After considerable experimentation with solvents, 
temperature and additives, we found that PIFA is more efficient than 39. The proper choice 
of a solvent is very important. Protic solvents with low nucleophilicity, such as 2,2,2-
trifluoroethanol and 1,1,1,3,3,3-hexafluoropropanol, mmed out to be the best. To neutralize 
any acid generated, an additive of inorganic base, such as potassium carbonate or 
bicarbonate, was required. Non-aqueous basic workup, followed by flash chromatography, 
also improved the overall yield. After all of these modifications, we were able to achieve a 
62% yield of 8-deoxy 1X1-81 (40). This is the highest reported yield for this type of 
oxidation (Scheme 23). The reaction proceeds within 2 hours at room temperature and is 
easily reproducible on 10-1000 mg scales. When the workup was omitted and the reaction 
mixture after concentration was chromatographed, we isolated an inseparable mixture of two 
unstable ketals 41 and 42, that serve as intermediates in this oxidation. Independent 
treatment of 41 and 42 with DBU resulted in their quantitative conversion to 40. However, 
15 
an attempt to use DBU as a base during oxidation showed its incompatibility with PIFA. 
Unfortunately, we were unable to determine the actual enantiomeric purity of the product. 
However, optical rotations of the starting amine 28 and the resulting imine 40 are very 
similar, suggesting no racemization at CI la. 
Scheme 23 
MeO 
PIFA 
CF3CH2OH 
MeO 
CF3CH2O 
PIFA. K2CO3, 
CF3CH2OH MeO 
62% 
41 
CF3CH2Q  ^
MeO 
CF3CH2O 
DBU. 
100% 
In summary, the direct preparation of 8-deoxy DC-81 (40) was achieved in four steps 
from conunercially available starting materials. The approach represents a direct and 
reproducible way for the synthesis of this class of compounds. The biological activity of this 
compound is expected to be comparable to that of DC-81, since the C8 substituent is reported 
to be interchanged with little effect on activity.'' PIFA oxidation proved to be a useful 
protocol for the introduction of the imine moiety into the pyrrolobenzodiazepine system. 
16 
Acyl radical approach 
In another attempt to synthesize the pyrrolobenzodiazepine system, we chose to 
develop an approach based on a recently developed^" acyl radical addition to benzoquinones. 
On the way towards creating an atom economical and environmentally benign alternative to 
the Friedel-Crafts reaction, photochemically-induced reaction between quinones and 
aromatic or aliphatic aldehydes is one of the most efficient and experimentally simple 
methods."' It is based on irradiation of a degassed solution of a quinone and an aldehyde, 
often in the presence of benzophenone as a sensitizer (Scheme 24). 
Scheme 24 
? RCHO r 2  ^
( 1  — ^ T O O C I _  1 ^  
PhaCO Lewis Acid 
O R = alkyi, aryl OH OH 
43 44 
The advantages of this method are clear: aldehydes are by far more accessible and 
stable than acyl halides, the use of corrosive catalysts is avoided, and the reactions never go 
beyond monosubstituted products, which can be easily separated from the starting materials. 
The reaction can be easily scaled up, remaining environmentally safe and inexpensive. 
Although this method works well with many aromatic and aliphatic aldehydes, it could not 
be extended to the synthesis of the analogous carboxamides 45, by using substituted 
formamides (Scheme 25). 
17 
Scheme 25 
O O OH O 
A R3N^H y NR, 
O OH 
43 45 
This is was a very disappointing result, since we envisioned a possibility of 
conversion of an appropriately substituted 45 into pyrrolobenzodiazepine dilactam 46. The 
reason for this failure lies in the inability to form a carboxamido radical by direct abstraction 
from the substituted formamide, a process that proceeds smoothly with most aldehydes 
(Scheme 26). 
Scheme 26 
o ^ o O o X - U X a • iJ 
R H BO R^' RaN H BO'' RgN 
To overcome this problem, we had to develop a new method of formation of both 
acyl and carboxamido radicals. In contrast to conventional methods for acyl radical 
formation, such as the reaction of phenylselenoesters with organotin reagents" and 
carbonylation of alkyl radicals,^ the synthesis of acyl radicals from keto acids via persulfate 
oxidation is a comparatively unexplored area. The formation of alkyl radicals from simple 
carboxylic acids by oxidation-decarboxylation, however, has good precedent.""* It was 
reported that simple monoamides of oxalic acid react with protonated heterocyclic systems in 
methylene chloride to afford heterocyclic carboxamides.^ Pyruvic acid was also shown to 
18 
react with substituted pyrimidines.'^ Our attempt to apply reported conditions to the reaction 
of pyruvic acid with benzoquinone led to a low yield of the desired acylhydroquinone. 
Instead of using an excess of acid for this reaction, we eventually found that the addition of 
2-5 equivalents of benzoquinone provided a significantly higher yield. One other positive 
aspect of this discovery is the fact that benzoquinone is usually less expensive than most of 
the keto or carboxamido acids. After experimentation with various solvent systems, we were 
able to conclude that substitution of a two-phase methylene chloride-water system with 
homogeneous water-acetonitrile also increased yields. Finally, ±e reaction proceeded 
smoothly for most of the substrates (Scheme 27). 
Scheme 27 
cat Ag* 
R= Me 44a 
R = Et 44b 
R= Ph 44c 
R = PhCHg 44d 
R = morphoiine 44e 
R = APrgN 
OH O 
The modest yield of acylhydroquinone 44d in the reaction with phenylpyruvic acid is 
probably due to competing decarbonylation of the resulting acyl radical to a stable benzyl 
radical. But the most important result was formation of morphoiine amide 44e that proved 
the possibility of generating a carboxamido radical by this method. The failure to produce 
19 
the diisopropyiamide was probably not because of a problem with radical generation, but 
rather with difficulty in addition of this bulky radical to benzoquinone. 
Most of our experiments were conducted on a I-10 mmol scale, but a similar yield of 
44a (91%) was obtained when we used 100 nmiol of pyruvic acid. This convinced us of the 
synthetic utility of this reaction on a larger scale as well. 
Now with this new method available to us, we began construction of the 
pyrrolobenzodiazepine skeleton. As a starting material we used methyl ester of proline (47). 
an inexpensive commercially available compound. Treatment of 47 with benzyl oxalyl 
chloride"^ and triethylamine in methylene chloride, followed by removal of the benzyl ester 
using catalytic hydrogenation (H2, 10% Pd/C in ethyl acetate, 2 hrs), provided amide acid 48 
in 95% overall yield (Scheme 28). 
Scheme 28 
Cy^COOMe Hg. Pd/C 
^ ^ O^COOBn O'^COOH 
47 48 
Now the stage was set for the key step of our approach, oxidative formation of the 
carboxamido radical, followed by addition to benzoquinone. The reaction of 48 with 5 
equivalents of benzoquinone using 1.2 equivalents of ammonium persulfate and a catalytic 
amount of silver nitrate afforded quinone carboxamide 49 in 62% isolated yield (Scheme 29). 
Overoxidation to benzoquinone did not constitute a problem and 49 after quantitative 
reduction upon catalytic hydrogenation (H2, 10% Pd/C in ethyl acetate, 20 min) was 
converted to amide 50 after reaction with ammonia in methanol at ambient temperature in 
20 
11% yield (Scheme 30). Oxidation with silver(I) oxide in ether resulted in formation of 
quinone 51, which was cyclized upon treatment with trifluoroacetic anhydride and 
triethylamine. Finally, catalytic hydrogenation (Ho, 10% Pd/C in ethyl acetate. 30 min) of 
iminoquinone furnished tricyclic PBD dilactam 46 in 83% jdeld over three steps. The 
selective reduction of one of the lactams to the carbinol amine has already been described." 
Scheme 29 
COOMe 
O'^COOH 
48 
(NH4)2S208 
cat AgNOs 
62% 
Scheme 30 
O O COOMe 9"  ^ 9 COOMe 
Hz, Pd/C '^ '^ 3 
OH O 
AgaO 
77% 
(two steps) 
O O CONH 2 
TFAA 
EtsN o 
CONH; 
Ha, Pd/C 
83% HO 
(three steps) 
50 
H .0 
The convergent synthesis of a PBD dilactam was made possible by a novel reaction 
of the amide acid 48 with benzoquinone. This radical reaction has the advantages of 
inexpensive reagents and a convenient experimental procedure. The developed method of 
21 
acyl and carboxamido hydroquinones has a broader scope of application in comparison with 
the photochemical method and is more environmentally benign than the corresponding 
Friedel-Crafts reaction. 
Conclusions 
This study introduced two new approaches to pyrrolobenzodiazepines. A number of 
improvements over existing methods were developed in the first approach. We have shown 
the great potential of PIFA for oxidation of the easily prepared saturated amine. Now with a 
possibility of preparation of PBDs on a larger scale, an extensive biological smdy can be 
conducted. The results may play an important role in development and manufacturing of 
new therapeutic agents. In the second approach, we found an interesting alternative to the 
Friedel-Crafts reaction in the synthesis of acyl and carboxamido hydroquinones. This 
method features a new way for generating acyl radicals and has the potential to become one 
of the most efficient. It may find its application in manufacturing of this class of compounds 
on an industrial scale. At the same time, we have demonstrated its synthetic utility for the 
construction of the pyrrolobenzodiazepine skeleton. 
Experimental 
Unless otherwise noted, materials were obtained from commercial suppliers and were 
used without purification. Diethyl etiier and tetrahydrofuran (THF) were distilled from 
sodium benzophenone ketyl. Benzene was distilled from lithium aluminum hydride. 
Toluene and methanol were distilled from sodium. Dichloromethane and acetonitrile were 
distilled from calcium hydride. All reactions were conducted imder an argon atmosphere and 
all extracts were dried over anhydrous magnesium sulfate. Glassware for experiments 
requiring anhydrous conditions were flame-dried under a stream of argon or in a I50°C oven 
for 12 hours and cooled in dessicator. Silica gel chromatography (sgc) was performed on 
EM Science Kieselgel 60 (mesh 230-400). Thin layer chromatography (tic) was performed 
using EM Science Kieselgel F254 prepared plates with a thickness of 0.25 mm. The solvent 
systems were suitable mixtures of hexanes (H) and ethyl acetate (EA) unless otherwise noted. 
Infrared spectra were obtained on a Perkin-Elmer 1320 spectrophotometer and are reported in 
cm '. Proton nuclear magnetic resonance spectra (300 Mz) were obtained using a Varian 300 
spectrometer. All chemical shifts are reported in 6 relative to the solvent peak and/or 
tetramethylsilane as an internal standart. Splitting patterns are designated as s (singlet), d 
(doublet), t (triplet), q (quartet), dd (doublet of doublets) and m (multiplet); the addition of br 
indicates a broadened pattern. Carbon-13 NMR spectra (75.46 MHz) were obtained on a 
Varian 300 spectrometer and are reported in 5 relative to CDCI3 (77.0 ppm) as an internal 
standard. High-resolution mass spectra (HRMS) were obtained on a Kratos model MS-50 
spectrometer. Low-resolution mass spectra (MS) were obtained on a Finnigan 4023 mass 
spectrometer. The purity of all title compounds was determined to be >95% by 'H NMR 
spectral determination. 
(2S)-iV-(5-Methoxy-2-hydroxybeiizoyl)-2-(diloromethyl)pyrrolidine (26). To a 
stirred solution of dihydroxyamide 25'" (251 mg, 1.00 nraiol) in dry methylene chloride (5 
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mL) under Ar at 0 °C was added pyridine (1 mL) followed by para-toluenesulfonyl chloride 
(200 mg, 1.05 mmol). The resulting mixture was allowed to warm to rt overnight and then 
was diluted with methylene chloride (20 mL). The organic layer was washed with IM 
aqueous sulfuric acid (2 x 10 mL), water and brine and dried over magnesium sulfate. 
Evaporation of the solvent followed by sgc (H:EA 4:1) provided compound 26 (131 mg. 
49%) as a clear oil. Further elution with change of the solvent system to H:EA 1:1 gave a 
mixmre of tosylates (186 mg, 46%). 'H NMR (CDCI3) 5 1.70-1.80 (m, 1 H), 2.01-2.22 (m, 
3H). 3.65-3.86 (m, 3H), 3.76 (s, 3H). 3.94-3.99 (m, IH), 4.55-4.63 (m, IH), 6.89-6.97 (m. 
3H) 10.07 (br s, IH). NMR (CDCI3) 6 25.6, 28.1, 45.8, 52.3, 56.1, 58.3, 113.5, 117.4. 
118.5. 119.4, 151.4, 153.8, 170.7. IR (neat) cm ' 3154, 1581, 1449. MS m/z (ED 269 (M"^. 
^'Cl. 55%) 271 (M"^, ^'Cl, 18%). HRMS m/z (M"^, ^^Cl): 269.08145. calcd for 
CijHieNOs^^Cl: 269.08187. 
(25)-A^-(5-Methoxy-2-iiitobeiizoyl)pyrrolidinemethanol (34). To a suspension of 
5-methoxy-2-nitrobenzoic acid (197 mg, I mmol) in dry methylene chloride (10 mL) cooled 
to 0°C were added 4-methylmorpholine (0.22 mL, 2 mmol), EXTC (216 mg, 1.05 mmol) and 
A^-hydroxybenzotriazole (135 mg, 1 mmol) followed by (S)-(+)-2-pyrrolidinemethanol (101 
mg, 1 nmiol). The resulting mixture was stirred for 12 h at rt then filtered, washed with 
water and brine and dried over magnesium sulfate. The solvent was then removed in vacuo 
to give a crude residue, which was puritied by sgc (EA) to give 34 (263 mg, 94%) as a light-
yellow oil. 'H NMR(CDCl3) 6 1.69-1.89 (m, 3H), 2.09-2.18 (m, IH), 3.14-3.18 (m, 2H), 
3.76-3.85 (m, 2H), 3.89 (s, 3H), 4.32-4.37 (m, IH), 4.44 (br s, IH) 6.83 (d, J = 2.7 Hz, IH), 
6.96 (dd, J = 9.3, 2.7 Hz, IH), 8.17 (d, J = 9.3 Hz, IH). NMR (CDCI3) 6 24.4,28.5,49.7, 
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56.4,61.6, 112.8, 114.9, 127.5, 136.0, 137.5, 164.7. IR (neat) cm"' 3392, 1621, 1588, 1516. 
HRMS m/z (M - HjO)^: 262.0947, calcd for C,3H,4N204: 262.0954. 
(25)-iV-(5-Methoxy-2-iiitrobeiizoyl)pyrroIidine-2-carboxaIdehyde (35). A 
solution of 34 (168 mg, 0.6 mmol) in methylene chloride (3 mL) was added to a stirred 
solution of Dess-Martin reagent (280 mg, 0.66 mmol) in methylene chloride (5 mL). After 
30 min the reaction mixture was diluted with ether (10 mL), quenched with 20% aqueous 
sodium thiosulfate (3 mL) and saturated aqueous sodium bicarbonate (5 mL) and stirred for 
10 more min. Aqueous phase was separated, extracted with ether (10 mL), combined organic 
fractions washed with water and brine and dried over magnesium sulfate. Evaporation of the 
solvent followed by sgc (H:EA, 1:2) afforded the aldehyde 35 (138 mg, 83%) as a pale 
yellow oil. 'H NMR (CDCI3) for major rotamer 5 1.83-1.97 (m, 2H), 2.03-2.22 (m, 2H), 
3.19 - 3.33 (m, 2H), 4.63 (td, J = 3.4, 1.7 Hz, IH), 6.85 (d, J = 2.7 Hz, IH), 6.99 (dd, J = 9.3, 
2.7 Hz, IH), 8.18 (d, J = 9.3 Hz, IH), 9.74 (d, J = 1.7 Hz, IH). NMR (CDCI3) 6 24.9, 
26.5,48.6,56.3,64.9, 113.2, 115.0, 127.4, 135.3. 137.7, 164.3, 164.6, 199.3. IR (neat) cm ' 
1731, 1638, 1588, 1516. HRMS m/z (M - CHO)+: 249.0878, calcd for C12H13N2O4 
249.0875. 
(lla5)-7-Methoxy-l^ ,^10,ll»lla-hexahydro-5^-pyrrolo[2.1-
c][l,4]beii2odiazepin-5-one (29). The nitroaldehyde 35 (112 mg, 4 mmol) was dissolved in 
MeOH (5 mL) and hydrogenated over 10% Pd/C catalyst (10 mg). After 2 h an additional 
equal portion of the catalyst was added and hydrogenation continued for 3 more hours (or 
until the required volume of hydrogen was consumed). The catalyst was filtered, MeOH 
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removed in vacuo and resulting amine recrystallized from ethanol to give pure 29 (71 mg, 
11%) as pale yellow plates (mp 237 °C). 'H NMR (CDQs) 5 1.64-1.75 (m. IH). 1.82-2.00 
(m, 2H), 2.14-2.25 (m, IH) 3.26 (dd, J = 12.0, 9.6 Hz, IH), 3.52 (dd, J = 12.0, 2.5 Hz. IH), 
3.77 (s. 3H), 3.65-3.90 (m, 4 H), 6.56 (d, J = 9.0 Hz, IH), 6.84 (dd, J = 9.0. 3.0 Hz. IH), 7.49 
(d, J = 3.0 Hz, IH). NMR (CDCb) 5 23.0. 30.5, 48.0, 54.1. 55.8, 57.0, 114.4, 120.3, 
120.7, 121.4, 139.8, 152.6, 167.0. IR (neat) cm ' 3320, 1593, 1573. [alD""^ 3.67 (c 1.25, 
CHCI3). Anal calcd for CiaHieN.O^, C, 67.22; H. 6.94; N, 12.06, found : C, 67.23; H, 7.21; 
N, 11.97. 
(llaS)-7-Methoxy-l^ ,^lla-tetrahydro-5H-pyrrolo[2.1-c][l,4]benzodiazepin-5-
one (40). To a stirred solution of amine 29 (50 mg, 0.22 mmol) in 2,2,2-trifluoroethanol (5 
mL), containing potassium carbonate (104 mg, 0.87 mmol) under Ar was added a solution of 
[bis(trifluoroacetoxy)iodo]benzene (93 mg, 0.22 nunol) in CF3CH2OH (3 mL) dropwise over 
30 min. The resulting mixture was stirred for an additional 2 h, then solvent removed in 
vacuo, the residue was dissolved in 5 mL THF and stirred for 20 min. Removal of solvent 
followed by sgc (EA) gave the imine 40 (31 mg, 62%) as a colorless oil. 'H NMR (CDCI3) 6 
2.02-2.09 (m, 2H), 2.27-2.34 (m, 2H), 3.51-3.60 (m, IH), 3.69-3.75 (m, IH), 3.78-3.84 (m, 
IH), 3.87 (s, 3H). 7.07 (dd, /= 9.0, 3.0 Hz, IH), 7.25 (d, 7 = 9.0 Hz, IH), 7.51 (d, 7= 3.0 Hz, 
IH), 7.67 (d, / = 4.2 Hz, IH). '^C NMR (CDCI3) 5 24.2, 29.7,46.8, 53.6, 55.7, 112.6, 119.5, 
128.8, 129.0, 139.7, 157.9, 162.5, 164.7. IR (neat) cm*' 1627, 1604, 1450, 1436. HRMS m/z 
(M-H)"^: 229.0979, calcd for CuHijNiOa: 229.0977. 8.21 (c 1.25, CHCI3). 
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Ketal 42. When the residue after concentration was treated with chloroform instead 
of THF it afforded after evaporation of the solvent mainly an unstable ketal 42 as a mixture 
of isomers. 'H NMR (CDCI3) 5 1.60-1.89 (m, 3H), 2.21-2.37 (m, IH), 3.18-3.25 (m. IH). 
3.41 and 3.46 (s, 3H), 3.47-4.33 (m, 8H), 4.93 and 5.05 (br d, IH), 4.96 and 5.37 (d, 7 = 2 
Hz. 1 H), 5.83-5.89 (m, IH), 5.95-5.99 (m, IH). MS m/z (CI) 431 (M+I), 331. 
Cyclophane 32. Spectral data: 'H NMR (CDCI3) 5 1.40-1.47 (m, IH), 1.83-2.04 (m, 
3H) 3.41-3.58 (m, 2 H), 3.78-3.88 (m, IH), 3.79 (s. 3 H), 4.01-4.06 (m, 2H), 6.93-6.94 (m, 
2H), 7.04-7.05 (m, IH). NMR (CDCI3) 6 26.5, 31.6, 51.0. 56.1, 58.1. 63.0, 112.5, 112.8, 
118.2, 119.0, 151.1, 155.6, 169.6. MS m/z (EI) 232, 217. HRMS m/z (M^: 232.12123, 
calcd for Ci3H,6N202: 232.12118. 
Representative experimental procedure for an oxidative addition of keto and 
carboxamido acids to benzoquinone: A solution of amide acid 48 or analogous keto acid 
(1 mmol), benzoquinone (5 mmol), ammonium persulfate (1.2 mmol) and silver nitrate (0.2 
mmol) in 30 mL of 1:1 acetonitrile:water was heated at 70 °C for 2 hours. The resulting 
brown solution was diluted with methylene chloride. The organic layer was washed with 
water and dried over magnesium sulfate. After removal of the solvent in vacuo, the residue 
was purified by silica gel chromatography using 2:1 hexanes:ethyl acetate to afford 162 mg 
(62% yield) of quinone 49 (or acylhydroquinones 44a-e with the yields reported below). 49: 
This compound is a 70:30 mixmre of two rotamers. NMR (CDCI3) 5 1.97-2.34 (m, 4 H), 
3.30-3.35 and 3.45-3.53 (m, 1 H), 3.32-3.35 and 3.72-3.77 (m, 1 H), 3.65 and 3.77 (s, 3 H), 
4.10-4.15 and 4.62-4.66 (m, 1 H), 6.67-6.84 (m, 3 H). NMR (CDCI3) 6 22.7, 24.7, 29.3, 
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31.1.46.5,48.2,52.6,52.8,58.7,60.1,133.1, 133.3, 136.2, 136.6, 136.7, 142.9, 143.1, 162.5, 
162.6. 171.8, 172.1, 184.2, 184.4, 186.7, 186.8. HRMS: m/z calculated for (M - C02Me) 
Ci 1H10NO3: 204.0661; measured: 204.0657. MS (O - NH3) 264 (M+1), 281 (M+18). 
2'^*-Dihydroxyacetophenone (44a). Following the general procedure described 
above and starting with pyruvic acid, 44a was isolated in 91% yield with the spectral 
characteristics identical to those of the conunercially obtained sample. 
2*3'-Dihydroxypropiophenone (44b). Following the general procedure described 
above and starting with 2-ketobutyric acid, 44b was isolated in 92% yield with the spectral 
characteristics identical to those of the commercially obtained sample. 
2^-Dihydroxybeiizophenone (44c). Following the general procedure described 
above and starting with benzoylformic acid, 44c was isolated in 73% yield with the spectral 
characteristics identical to those of the conunercially obtained sample. 
Benzyl 2^-dihydroxyphenyl ketone (44d). Following the general procedure 
described above and starting with phenylpyruvic acid, 44d was isolated in 18% yield with the 
spectral characteristics identical to those previously reported."' 
iV-(23-Dihydroxybenzoyl)morpholme (44e). Following the general procedure 
described above 44d was isolated in 53% yield. 'H NMR (CDCI3) 6 3.66 (s, 8H), 6.05 (br s, 
IH), 6.70 (dd, y = 2.1, 5.4 Hz, IH), 6.78 (d, 7 = 2.1 Hz, IH), 6.80 (d, / = 5.4 Hz, IH). 
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NMR ((CD3)2C0) 8 66.5, 66.6, 114.4, 117.2, 118.2, 121.6, 148.4, 149.9, 168.4. IR (neat) 
cm ' 3120. 1620, 1580. HRMS: m/z calculated for C11H13NO4: 223.0844; measured: 
223.0847. 
(llaS)-7-Hydroxy-l^ ,^lla-tetrahydro-5H-pyrroio[2.1-c][l,4]beiizodiazepiii-
5,ll-<iione (46). Amide 50 (0.5 nrniol) was dissolved in diethyl ether (20 mL) and stirred 
with an excess of silver (I) oxide (2.5 nraiol) for 12 hrs. The resulting solution was filtered 
and concentrated under reduced pressure. The residue was dissolved in methylene chloride 
and treated with TFAA (0.5 mmol) and triethylamine (0.55 mmol). After 2 hrs the reaction 
mixture was partitioned between methylene chloride and aqueous sodium bicarbonate, 
organic layer washed with water and dried. After removal of the solvent the residue was 
dissolved in ethyl acetate and stirred under the atmosphere of hydrogen in the presence of 
10*!^^ Pd-C catalyst (20 mg) for 30 minutes. Filtration, concentration and sgc afforded the 
title compound (90 mg, 83%) as a light-yellow oil. 'H NMR (CDCI3) 5 1.92-2.40 (m, 4H), 
3.80 (I, y = 6.1 Hz, 2H), 4.85 (t, J = 6.6Hz, IH), 5.53 (br s, IH), 6.85-6.93 (m, 3H), 9.80 (br 
s, IH). J3C NMR (CDCI3) 5 25.7, 30.2, 48.2, 50.4, 114.0, 116.2, 118.4, 119.0, 121.9, 147.6, 
153.8, 170.7. HRMS: m/z calculated for C12H12N2O3: 232.0848; measured: 232.0849. 
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CHAPTER 2. SYNTHESIS OF 1,4-PHENANTHRENEQUINONES 
A paper, a portion of which was submitted to The Journal of Organic Chemistry-
George A. Kraus and Alex Melekhov 
Introduction 
Para-quinones are useful building blocks in the construction of a wide variety of 
molecules. A number of natural products include the quinone moiety as the pharmacophore. 
Consequently, considerable research has been done regarding this class of compounds.' 
However, most of the studies have focussed on only three types of common para-quinones, 
benzoquinones 1, naphthoquinones 2 and anthraquinones 3 (Scheme 1). 
Phenanthrenequinones 4, tricyclic aromatic compounds isomeric to anthraquinones, on the 
other hand, have received little attention although they have been known for 70 years." 
Scheme 1 
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A number of phenanthrenequinones are biologically active such as cypripedium (5) 
and danshenxinkuns B (6, R=i-Pr) and C (6, R=Me)^ (Scheme 2). They may also serve as 
intermediates in the construction of polycyclic quinones and other angularly fused ring 
systems. It was also shown that certain phenanthrenequinones can be transformed into 
helicenes by a sequence of Diels-Alder reactions.'^ The development of the good synthetic 
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method to prepare phenanthrenequinones, a method that would allow a straightforward and 
regioselective preparation of this class of compounds with various substitution patterns, 
would be valuable. 
Scheme 2 
o o 
.OMe 
MeO 
HO 
Me OH 
5 6 
The are two approaches that lead to phenanthrenequinones, photochemical cyclization 
of stilbenes or Diels-Alder reactions involving styrenes and benzoquinones. In the first one, 
certain stilbenes 7 underwent cyclization upon irradiaton in the presence of oxidizing agents 
such as iodine affording 1,4-dimethoxyphennathrenes 8 (Scheme 3).^ Deprotection with 
TMSI in the presence of the oxygen eventually resulted in the formation of 
phenanthrenequinones. 
Scheme 3 
hv TMSI 
O2 
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This method has several disadvantages such as long irradiation times, very dilute solutions 
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for irradiation and necessity of preparation of the stilbenes. The reaction can be successfully 
done only on a limited number of substrates because of the instability of many functional 
groups under TMSI cleavage conditions. 
In the other approach, benzoquinones were reacted with substituted styrenes 9 in 
boiling xylene resulting in direct formation of 4 in 20-30% yield (Scheme 4).® Later, 
application of trichloroacetic acid as a catalyst slightly improved the overall result/ 
Scheme 4 
[O] 
This reaction was used in the preparation of a key intermediate in the synthesis of chartreusin 
Q 
aglicone. Recently, several new modifications of this method were published. The activity 
of the dienophile in this cycloaddition was increased by the introduction of 
arylsulfinylbenzoquinone 10 (Scheme 5).' On the other hand, the diene component was 
enhanced by an innovative use of a silicon tether 11.'° 
Scheme 5 
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Several years ago, with the development of ultrasound-promoted Diels-Alder 
reactions, the preparation of more sophisticated phenanthrenequinones became possible, as 
shown by the synthesis of danshenxinkuns B and C (6) and plectranthons C and D." The 
comparison with the conventional thermal method indicated the higher efficiency of this 
technique. However yields still remained under 30%. The medical and chemical 
significance of phenanthrenequinones was confirmed once again during an extensive srndy'" 
of the Chinese traditional drug "Don Shen" when several representatives of this family were 
found to play an active role in the therapeutic effect of this drug. 
One of the biggest disadvantages of the existing methods is a failure to generate 5-
substituted phenanthrenequinones 12 (Scheme 6). This is due to a known strain existing 
between groups at C4 and C5 of phenanthrenes. Since several naturally-occurring quinones 
include this pattern of substitution, these synthetic strategies can not be applied to them. 
Scheme 6 
12 
OH 
One of the most elegant methods for the regioselective synthesis of 
phenanthrenequinones and related angularly-fused polycyclic compounds appeared only 
recently.*^ The method is based on dual annulation reactions. One involves an electrocyclic 
ring opening of substituted cyclobutenones 13 prepared from dimethyl squarate (14) to 
vinylketenes and their subsequent reaction with proximally-placed ketenophiles (Scheme 7). 
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The other reaction constitutes a new metathesis sequence leading to aromatic rings after 
photofiragmentation. The overall yield of this sequence was 62% but it took 8 steps and was 
not reported for the quinones with C4-C5 strain. 
Scheme 7 
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Methoxy-substituted phenanthrenequinones were also used as key intermediates in 
the synthesis of hydroxydibenz[a,j]anthracenes 15 and hydroxydibenz[a,h]anthracenes 16, 
important metabolites found in mammalian metabolism''^ (Scheme 8). 
Scheme 8 
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Diels-Alder reaction with styrene as diene followed by reduction with Zn/AcOH and 
demeihylation (LiSMe/DMF) afforded 15 and 16 in modest yield in a very straightforward 
fashion. 
In view the existing methods for the synthesis of phenanthrenequinones, the need for 
a new method of quinone preparation becomes obvious. 
Results and Discussion 
Synthesis of 1,4-Phenanthrenequinones 
We wanted to devise a method that would allow a regioselective formation of 
phenanthrenequinones. Connection of two substituted aromatic rings via a two-carbon 
bridge followed by cyclization was evaluated. Earlier studies^ showed that the 
photochemically-induced radical cyclization was not efficient. Intending to prepare quinones 
with electron-rich substituents we chose to proceed with the Lewis acid-mediated 
electrophilic cyclization. 
The route begins with arylacetaldehydes 17a-g which are readily available by two 
different methods that both provide very high yields. One involves borane reduction of 
substituted arylacetic acids followed by Dess-Martin oxidation'^  (method A, used for 17b-e). 
Another proceeds by formation of an epoxide from the substituted benzaldehydes, followed 
by boron trifluoride induced rearrangement'^ (method B, used for 17f-g) (Scheme 9). In our 
experience, in method A, the Dess-Martin oxidation proved to be superior to the Swem 
oxidation (DMSO, (CCX11)2) and the PCC oxidation. 
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17a R^=r2=r3=r'»=h 
17b R^=r2=R'»=H R^=OMe 
17c R^=R'*=HR2=R®=OMe 
17d R^=R'*=OMe R^=R^=H 
17e R'=HR^=R^=R'*=OMe 
17f R^=H R2=R'»=OBn R^=OMe 
17g R^=Br r2=H R^=OMe R'*=OBn 
Method B 
for 17f-g 
The resulting arylacetaldehydes were reacted with aryl lithium 18'^ from -78 "C to 
ambient temperature followed by deprotection with a catalytic amount of IM sulfuric acid in 
3:1 THFrwater to afford hydroquinones 19a-g in 70-76% yields (Scheme 10). 
Scheme 10 
CHO 
U. 
EEC 
OH OH OH O 
18 
2)H*,THF/H20 
66-79% 
DDQ 
91-96% 
17a-g 19a-g 20a-g 
The use of the ethoxyethyl protecting group was crucial, since attempted removal of 
the methoxymethyl protecting group led to partial deprotection plus significant dehydration 
of the benzylic alcohol, resulting in substituted styrenes. DDQ oxidation of 19 provided the 
corresponding hydroxy benzoquinones 20a-g in 90-95% yields. 
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At this point we were ready to attempt the key cyclization. For the initial cyclization 
studies we chose 3,4.5-trimethoxy hydroxyquinone 20e as a substrate and boron trifluoride 
etherate as a Lewis acid. We found that reaction proceeded in benzene or methylene chloride 
but failed in THF or ether. Is appeared that in these solvents the Lewis acid becomes 
deactivated due to solvation. We eventually chose methylene chloride because we were able 
to conduct reactions at low temperatures. Experimentation with several Lewis acids 
eventually led to the use of tin tetrachloride that provided somewhat better results. However, 
the highest yield we were able to reach was only 41%. Along with the product, hydroxy 
hydroquinone 19e was recovered. We explained it by a redox process between the starting 
quinone and initially formed phenanthrenehydroquinone 21 (Scheme 11). Elimination of the 
benzylic alcohol presumably occurred after cyclization but before oxidation to 
phenanthrenequinone. 
Scheme 11 
OH O 
MeO' ^0^  ^
OMe 
20e 
SnCU 
CHgCig 
MeO 
20e 
MeO 
+ 19e 
OMe 
To overcome this problem we introduced an internal oxidant to push the reaction to 
completion. After addition of one equivalent of DDQ, the isolated yield of 
phenanthrenequinone increased to 71%. All precursors 20a-g were then subjected to these 
cyclization conditions (Scheme 12) 
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Scheme 12 
OH O 
SnCl4. DDQ 
CH2CI2, -78®C-rt' 
20a R^=R^=R^=R'^ =H 
20b R'=r2=R'*=H R^=OMe 
20c R^=R'*=H R^=R^=OMe 
20d R'=R'*=OMe R^=R^=H 
20e R'=H R^=R^=R'*=OMe 
20f R'=H R^=R'^ =OBn R^=OMe 
20g R'=Br R^=H R®=OMe R'^ =OBn 
22a 74% 
22b 70% 
22c 68% 
22d 0% 
22e 71% 
22f 65% {R'*=OH) 
22g 0% 
Cyclization of compound 20f was accompanied by Lewis acid assisted cleavage of the 
benzyl group that is close to quinone carbonyl. Only one regioisomer was formed in the case 
of 20c. To our surprise and disappointment, hydroxy quinones 20c and 20g failed to 
generate phenanthrenequinone. In view of the successful cyclizations of other substrates, the 
failure of 20c and 20g to cyclize remains unclear. Since an ortho substituent is present in 
both 20c and 20g, non-bonded interactions between it and quinone may be sufficient to 
inhibit the reaction. 
The attempt to cyclize an acyl quinone 23, prepared by oxidation of 19e with 2 
equivalents of Dess-Martin reagent, led to the dimerized quinone 24 instead of 25 (Scheme 
13). Dimerization of phenols in the presence of DDQ proceeds via a radical formation and 
has a considerable precedent.'® 
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Scheme 13 
Dess-Martin 
DDQ 
dimerization 
Our phenanthrenequinones were tested for antiviral activity in vitro against the equine 
infectious anemia virus.'' The effect of 22b was the strongest and 22e somewhat lower 
(Figure I). The compounds were active both in the light and in the dark. 
Phenanthrenequinones 22a-c,e-f were prepared in five steps from commercially 
available arylacetic acids or benzaldehydes. This is an efficient protocol, allowing the 
preparation of quinones with C4-C5 strain. 
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Figure 1. Antiviral activity of synthesized phenanthrenequinones 
Approach to angularly-fused ring systems 
Having established an efficient synthesis of phenanthrenequinones, we decided to 
extend their applicability in the synthesis of angularly-fused aromatic ring systems. 
Recently, compounds like tetrangulol (26) and 6-hydroxytetrangulol (27) (Scheme 14) were 
reported to exhibit signiflcant biological activity. Utilizing phenanthrenequinones such as 
22e as a preassembled ring B, C and D system, all we had to do was to regioselectively 
construct the remaining ring A by a Diels-Alder reaction. We envisioned that the proximity 
of C4 and C5 substituents in phenanthrenequinones would allow us to reach this selectivity 
by either a steric or electronic effect. 
The calculations of molecular electrostatic potential maps"® indicated that an 
incoming l-trimethylsilyloxybutadiene should attack 22e with the OTMS group away from 
the C5 methoxyl group. In practice, this approach proved to be successful. 
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Scheme 14 
OH O X 
26(X=H) 27(X=OH) 
OH O 
22e 
The addition of 2 equivalents of 1-trimethyIsilyloxybutadiene to quinone 22e in 
methylene chloride from -78°C to ambient temperature afforded the Diels-Alder product, 
which was not isolated but after concentration was oxidized using the Jones reagent"' to 
furnish the substituted benz[a]anthracene 29 in 84% isolated yield. (Scheme 15). 
Scheme 15 
22e 
1) r^\-oms 
2) Jones oxidation 
84% OH O 
29 
No other quinone-containing products were detected. The regiochemistry of 29 was 
confirmed by an X-ray structure determination" (Figure 2). It is clear that the existing strain 
results in deformation of ring B and twisting of CI2 carbonyl group out of the aromatic plane 
while other rings remain virtually planar. 
43 
cm' 
.OQI en 
cnzj 
lOTI 
Figure 2. X-ray determined structure of 29. 
Conclusions 
In this work we developed a novel method for the synthesis of phenan±renequinones, 
a class of compounds that was found to play an important role in traditional Chinese 
medicine. Phenanthrenequinones are also very useful intermediates in the synthesis of many 
natural products. Certain quinones prepared by us also exhibit signiHcant antiviral activity. 
The development of this approach allows a quick and regioselective entry into this family of 
quinones. We also discovered a novel synthetic application of phenanthrenequinones by 
developing the method of substiment-controlled conversion into angularly fused 
benzanthracenes. We hope that our study will allow researchers to better explore the 
chemical and biological potential of this interesting class of compounds. 
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Experimental 
Unless otherwise noted, materials were obtained from commercial suppliers and were 
used without purification. Diethyl ether and tetrahydrofuran (THF) were distilled from 
sodium benzophenone ketyl. Benzene was distilled from lithium aluminum hydride. 
Toluene and methanol were distilled from sodium. Dichloromethane and acetonitrile were 
distilled from calcium hydride. All reactions were conducted under an argon atmosphere and 
all extracts were dried over anhydrous magnesium sulfate. Glassware for experiments 
requiring anhydrous conditions was flame-dried under a stream of argon or in a 150°C oven 
for 12 hours and cooled in dessicator. Silica gel chromatography (sgc) was performed on 
EM Science Kieselgel 60 (mesh 230-400). Thin layer chromatography (tic) was performed 
using EM Science Kieselgel F254 prepared plates with a thickness of 0.25 nwn. The solvent 
systems were suitable mixtures of hexanes (H) and ethyl acetate (EA) unless otherwise noted. 
Infrared spectra were obtained on a Perkin-Elmer 1320 spectrophotometer and are reported in 
cm"'. Proton nuclear magnetic resonance spectra (300 Mz) were obtained using a Varian 300 
spectrometer. All chemical shifts are reported in 6 relative to the solvent peak and/or 
tetramethylsilane as an internal standart. Splitting patterns are designated as s (singlet), d 
(doublet), t (triplet), q (quartet), dd (doublet of doublets) and m (multiplet); the addition of br 
indicates a broadened pattern. Carbon-13 NMR spectra (75.46 MHz) were obtained on a 
Varian 3(X) spectrometer and are reported in S relative to CDCI3 (77.0 ppm) as an internal 
standard. High-resolution mass spectra (HRMS) were obtained on a Kratos model MS-50 
spectrometer. Low-resolution mass spectra (MS) were obtained on a Finnigan 4023 ma!g«; 
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spectrometer. The purity of all title compounds was determined to be >95% by 'H NMR 
spectral determination. 
3,4^-Trimethoxyphenylacetaldehyde (17e). To a stirred solution of 3,4,5-
trimethoxyphenylacetic acid (1.13 g, 5 mmol) in dry THF (20 mL) at 0°C under Ar was 
added IM THF solution of BH3.THF complex (10 mL, 10 mmol). After 4 h water was 
carefully added with cooling, the reaction mixture was diluted with ether, washed with 
NaHCOs solution, water and brine and dried. Solvents were removed in vacuo, the residue 
was dissolved in methylene chloride (20 mL) and added to a stirred solution of Dess-Martin 
reagent (2.54 g, 6 nmiol) in CHICIT (20 mL). After 1 h the solution was diluted with ether 
and stirred for an additional 10 min with a mixture of saturated aqueous NaHCOs (20 ntiL) 
and 25% aqueous Na2S203 (20 mL). The aqueous layer was separated, extracted with ether, 
combined organic fractions washed with sat. NaHC03. water and brine and dried. 
Evaporation of the solvents followed by sgc (20% EtOAc in hexanes) afforded pure aldehyde 
(0.90 g, 86%) as a clear oil which gave spectral data identical to that previously reported. 
4-Methoxyphenylacetaldehyde (17b). Following the general procedure described 
above and starting with 4-methoxyphenylacetic acid (0.83 g, 5 mmol), 17b (0.66g, 88%) was 
obtained as a clear oil which gave spectral data identical to that previously reported.^ 
3,4-Dimethoxyphenylacetaldehyde (17c). Following the general procedure 
described above and starting with (3,4-dimethoxyphenyl)acetic acid (0.98 g, 5 mmol), 17c 
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(0.76 g, 85%) was obtained as a clear oil which gave spectral data identical to that previously 
reported.^ 
23-Dimethoxyphenylacetaldefayde (17d). Following the general procedure 
described for 22e and starting with (2,5-dimethoxyphenyI)acetic acid (0.98 g, 5 mmol), 2,5-
dimethoxyphenylacetaldehyde (0.74 g, 83%) was obtained as a clear oil which gave spectral 
data identical to that previously reported.^ 
(5-Benzyloxy-2-bromo-4-inethoxyphenyl)acetaldehyde (17g). To a solution of 5-
benzyIoxy-2-bromo-4-methoxybenzaldehyde"' (321 mg, 1 mmol) in CH2CI2 (4 mL) were 
added trimethylsulfonium methylsulfate (245 mg, 13 nmiol) and 50% aqueous NaOH (0.5 
mL) and the resulting mixture was vigorously stirred for 3 h at rt. Water (5 mL) and ether 
(10 niL) were added and ±e organic phase separated. The aqueous phase was extracted with 
ether (10 mL), the combined organic fractions were washed with water and brine and dried. 
After removal of the solvents the residue was dissolved in dry THF (10 mL) and treated with 
BFs.EtiO (13 pL, 0.1 nunol). After 0.5 h the solution was diluted with ether, washed with 
water and brine and dried. Concentration followed by sgc purification of the residue (15% 
EtOAc in hexanes) afforded 17g (275 mg, 82%) as a clear oil. 'h NMR (CDCI3) 6 3.72 (d, J 
= 1.8 Hz, 2 H), 3.87 (s, 3 H), 5.10 (s, 2 H), 6.74 (s, 1 H) 7.10 (s 1 H), 7.30-7.42 (m, 5 H), 
9.67 (t, y = 1.8 Hz, 1 H). NMR (CDCI3) 5 50.1, 56.3, 71.4, 115.7, 116.2, 116.9, 124.2, 
127.5, 128-2, 128.7,136.5, 147.9, 149.9, 198.7. IR (neat) cm ' 2950, 1735, 1533. 
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2-(3,4,5-Trimethoxyphenyl)-l-(2^-dihydroxyphenyl)ethanol (19e). To a stirred 
solution of l,4-bis-(l-ethoxyethoxy)-benzene (1.10 g, 4.31 mmol) in ether (20 mL) at 0°C 
under Ar was added t-BuLi (1.65M in pentane, 2.50 ml, 4.12 nmiol) and the resulting 
solution was stirred for 0.5 h. It was cooled to -78°C, a solution of 17e (824 mg, 3.92 mmol) 
in dry THF (5 mL) was added dropwise via a syringe pump and the resulting mixture was 
allowed to slowly warm to rL Saturated NH4CI was added aqueous layer extracted with ether 
and combined organic fractions were washed with water. After concentration in vacuo the 
residue was dissolved in 4:1 THF-H2O (50 mL) and treated with 5 drops of IM H2SO4. After 
complete deprotection (TLC, ca. 4-6 hrs), ether was added. The aqueous layer was extracted 
with ether and the combined organic fractions were washed with water and brine and dried. 
Removal of the solvent followed by sgc (30% EtOAc in hexanes) afforded 19e (929 mg, 
74%) as a slowly solidifying clear oil. 'H NMR ((CD3)2C0) 5 2.88 (dd, 7 = 8.1, 13.5 Hz, 1 
H), 3.01 (dd, J = 5.4, 13.5 Hz, 1 H), 3.68 (s, 3 H), 3.75 (s, 6 H), 4.71 (br d, 7 = 3.6 Hz, 1 H), 
5.06 - 5.09 (m, 1 H), 6.50 (s, 2 H), 6.57 (dd, J = 3.0, 8.4 Hz, 1 H), 6.64 - 6.67 (m, 2 H), 7.62 
(br s, 1 H), 8.02 (br s, 1 H). NMR ((CX)3)2CO) 5 44.5, 55.4, 59.6, 72.8, 107.1, 113.8, 
114.2, 116.3, 130.7, 134.8, 136.8, 147.7, 150.2, 153.1. IR (neat) cm ' 3366, 1594, 1495. 
2-Phenyl-l-(2^-dihydroxyphenyl)ethanol (19a). Following the general procedure 
described above and using commercially available phenylacetaldehyde (335 mg, 2.79 mmol) 
as a starting material, 19a (455 mg, 71%) was obtained as a white foam. 'H NMR (ODCls) 5 
3.01 (d, 7 = 6.3 Hz, 2 H), 3.78 (br s, 1 H), 4.87 (t, J = 6.3 Hz, I H), 6.39 (d, 7 = 3.6 Hz, 1 H), 
6.58 (dd, 7 = 7.8, 3.6 Hz, 1 H), 6.63 (d, 7= 7.8 Hz, 1 H), 6.73 (br s, 1 H), 7.11-7.24 (m, 5 H), 
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7.77 (brs, 1 H). '^C NMR (CDCI3) 5 44.0, 75.9, 114.0, 115.5, 117.6, 126.8, 128.1, 128.6, 
129.6, 137.8, 148.6, 149.2. IR (neat) cm"' 3390, 1634, 1497. 
2-(4-Methoxyphenyl)-l-(2^-dihydroxyphenyi)etlianol (19b). Following the 
general procedure described above and using 17b (168 mg, 1.12 nunol) as a starting material, 
19b (204 mg, 70%) was obtained as a clear foam. 'H NMR ((CD3)2CO) 5 2.85 (dd, J = 8.4, 
13.5 Hz, 1 H), 2.99 (dd, J = 4.5, 13.5 Hz, 1 H), 3.75 (s, 3 H), 4.68 (d, J = 4.5 Hz, 1 H), 5.00-
5.05 (m, 1 H), 6.55 (dd, J = 3.0,9.3 Hz, 1 H), 6.64 (d, J = 9.3 Hz, 1 H), 6.68 (d, J = 3.0 Hz, 1 
H), 6.80 (d, J = 8.7 Hz, 2 H), 7.14 (d, / = 8.7 Hz, 2 H), 7.73 (s, 1 H), 8.09 (s, 1 H).). 
NMR ((CD3)2C0) 5 43.4, 54.6, 72.8, 113.4, 113.7, 114.1, 116.2, 130.6, 131.0, 131.3, 147.6, 
150.2, 158.3. IR(neat) cm ' 3370, 1601, 1490. 
2-(3,4-Dimethoxyphenyl)-l-(2^-dihydroxyphenyl)ethanol (19c). Following the 
general procedure described above and using 17c (520 mg, 2.89 mmol) as a starting material, 
19c (636 mg, 76%) was obtained as a white foam.. 'H NMR ((CD3)2CO) 5 2.87 (dd, 7= 8.1, 
13.5 Hz, 1 H), 3.00 (dd, J = 4.8, 13.5 Hz, 1 H), 3.72 (s, 3 H), 3.75 (s, 3 H), 4.69 (d, J = 4.2 
Hz, 1 H), 5.01-5.07 (m, 1 H), 6.56 (dd, J = 2.7, 8.4 Hz, 1 H), 6.63-6.66 (m, 2 H), 6.72-6.76 
(m, 2 H), 6.81 (d, J = 7.8 Hz, 1 H), 7.65 (s, 1 H), 8.04 (s, 1 H). ). NMR ((CD3)2CO) 6 
43.8, 55.1,55.3, 73.0, 111.8, 113.7, 113.8, 114.1, 116.2, 121.7, 130.8, 131.8, 147.7, 148.0, 
149.1, 150.2. IR(neat) cm ' 3400, 1592, 1514. 
2-(2^-Dimethoxyphenyl)-l-(2^-dihydroxyphenyl)ethanol (19d). The addition of 
aryllithium 18 to 2,5-dimethoxyphenylacetaldehyde (430 mg, 2.39 mmol) following the 
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general procedure described for 19e, afforded 2-(2,5-dimethoxyphenyl)-l-(2.5-
dihydroxyphenyl)ethanol (499 mg, 72%) as a white foam, 'h NMR ((CD3)2C0) 6 2.95-3.05 
(m, 2 H). 3.67 (s, 3 H), 3.76 (s, 3 H), 4.85 (d, 7 = 4.5 Hz, 1 H), 5.07-5.11 (m. 1 H), 6.55-6.73 
(m, 5 H), 6.74 (s, 1 H), 6.85 (d, 7 = 8.7 Hz, 1 H), 7.70 (s, 1 H), 8.11 (s, 1 H). '^C NMR 
((CD3)2C0) 5 38.8, 54.9, 55.6, 72.3, 111.4, 111.7, 113.8, 114.3, 116.4, 117.4, 128.3, 130.5, 
148.1, 150-1, 152.1, 153.5. IR (neat) cm ' 3390, 1590, 1505. 
2-(3,43-Triinethoxyphenyl)-l-(3,6-dioxo-l,4-cyclohexadienyl)ethanol (20e). To a 
chilled to ca. 10°C solution of 19e (880mg, 2.75 nmiol) in dioxane (15 mL) under Ar was 
added DDQ (655mg, 2.89 mmol) and the resulting mixture was stirred for 0.5 h. It was 
filtered, the filtrate was concentrated in vacuo and the residue purified by sgc (20% EtOAc in 
hexanes) to afford quinone 20e (831 mg, 95%) as a brown semisolid. 'H NMR (CDQj) 5 
2.36 (br s, 1 H), 2.57 (dd, J = 9.3, 13.5 Hz, 1 H), 3.09 (dd, J = 3.3, 13.5 Hz, 1 H), 3.81 (s, 3 
H), 3.84 (s, 6 H), 4.86 - 4.90 (m, 1 H), 6.46 (s, 2 H), 6.74 - 6.76 (m, 2 H), 6.83 - 6.85 (m, 1 
H). NMR (CDCI3) 5 44.0, 56.2, 60.9, 69.1, 106.3, 131.4, 133.0, 136.5, 136.8, 137.0, 
149.4, 153.4, 187.4, 187.7. IR (neat) cm ' 3441, 1658, 1586. 
2-Phenyl-l-(3,6-dioxo-l,4-€yclohexadienyl)ethanol (20a). Oxidation of 19a (141 
mg, 1.08 nunol) under the same conditions provided 20a (127 mg, 92%) as a brown foam. 
'h NMR (CDCI3) 5 2.24 (br s, 1 H), 2.71 (dd, J = 7.8, 13.5 Hz, 1 H), 3.15 (dd, J =3.3, 13.5 
Hz, 1 H), 4.88 - 4.91 (m, 1 H), 6.74 - 6.78 (m, 3 H), 7.23-7.35 (m, 5 H). NMR (CDOj) 6 
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43.5, 69.4, 127.2, 127.3, 128.9, 129.5, 131.6, 136.5, 136.8, 137.0, 187.4. 187.7. IR (neat) 
cm ' 3210, 1666. 1635. 
2-(4-]VIethoxyphenyl)-l-{3,6-dioxo-l,4-cyclohexadienyl)ethanol (20b). Oxidation 
of 19b (242 mg, 0.93 mmol) under the same conditions provided 20b (232 mg, 97%) as a 
yellow oil. 'H NMR (CDCI3) 5 2.14 (br s, 1 H), 2.65 (dd, J = 8.7, 13.5 Hz, 1 H), 3.10 (dd, J 
= 3.6, 13.5 Hz, 1 H), 3.80 (s, 3 H), 4.82-4.86 (m, 1 H), 6.71-6.79 (m, 3 H), 6.86 (d, J = 8.7 
Hz, 2 H), 7.15 (d, J = 8.7 Hz, 2 H). NMR (CDa,) 5 42.6, 55.4, 69.5, 114.3, 128.8, 
130.6, 131.6, 136.5, 136.8, 149.3, 158.8, 187.4, 187.7. IR (neat) cm ' 3480. 1657, 1612. 
2-(3,4-Diinethoxyphenyl)-l-(3,6-dioxo-l,4-cyclohexadienyl)ethanol (20c). 
Oxidation of 19c (330 mg, 1.14 nmiol) under the same conditions provided 20c (315 mg, 
96%) as a light-brown foam. 'H NMR (CDCI3) 5 2.19 (d, /= 6.3 Hz, 1 H), 2.63 (dd, 7= 8.7, 
13.5 Hz, 1 H), 3.11 (dd, J = 3.6, 13.5 Hz, 1 H), 3.86 (s, 3 H), 3.88 (s, 3 H), 4.84-4.88 (m, 1 
H), 6.75-6.81 (m, 6 H). '^C NMR (CDCI3) 5 43.2, 55.9,56.0, 69.3, 11.4, 112.5, 121.6, 129.5, 
131.5, 136.5, 136.8, 148.2, 149.2, 149.4, 187.4, 187.7. IR (neat) cm ' 3505, 2937, 1659, 
1516. 
2-(2^-Dimethoxyphenyl)-l-(3,6-dioxo-l,4-cyclohexadienyl)ethanol (20d). 
Oxidation of 2-(2,5-dimethoxyphenyl)-l-(2,5-dihydroxyphenyl)ethanol (296 mg, 1.02 mmol) 
under the same conditions as described for 20e provided 20d (273 mg, 93%) as a light-brown 
semisolid. 'H NMR (CDCI3) 5 2.97 (dd, J = 6.6, 13.5 Hz, 1 H), 3.11 (dd, J = 4.4, 13.5 Hz, 1 
H), 3.34 (d , y = 5.7 Hz, 1 H), 3.72 (s, 3 H), 3.73 (s, 3 H), 4.89-4.94 (m, 1 H), 6.57 (s, 1 H), 
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6.63-6.78 (m, 5 H). NMR (CDQs) S 37.9. 55.7, 56.1. 69.3. 111.6, 112.6. 117.8, 126.2, 
131.2, 136.3, 136.9, 149.7, 151.5, 153.8, 187.5. 187.8. IR (neat) cm ' 3494, 1660. 1515. 
2-(5-Beiizyloxy-2-bromo^methox3^henyl)-l-(3,6-dioxo-l,4-
cyciohexadienyl)ethanol (20g). Following the protocol described for 20e and staning with 
17g (101 mg. 0.30 mmol) 20g (99 mg. 74% over 2 steps) was prepared as a brown foam. 'H 
NMR (CDCI3) 5 2.45 (d 7 = 6 Hz. 1 H), 2.87 (dd, J = 7.8, 13.8 Hz. 1 H). 3.11 (dd. J = 4.8. 
13.8 Hz, 1 H), 3.83 (s, 3 H), 4.80-4.84 (m. 1 H). 5.10 (s. 2 H), 6.55 (s, 1 H). 6.68 (d. 7 = 9.9 
Hz, 1 H), 6.72 (d, /= 9.9 Hz, 1 H), 6.80 (s. 1 H). 6.98 (s. 1 H). 7.28-7.42 (m, 5 H). '^C NMR 
(CDCI3) 5 42.5, 56.3, 69.0, 71.3, 115.7, 116.1, 117.4, 127.6, 128.1, 128.2. 128.7, 131.6, 
136.3, 136.6, 136.9, 147.3, 148.7, 149.4, 187.5, 187.6. IR (neat) cm*' 3425, 1656. 1590. 
5,6,7-Trimethoxy-l,4-phenanthreneqiiinone (22e). To a solution of 
hydroxyquinone 20e (76 mg. 0.24 mmol) in dry methylene chloride (5 mL) at -78°C under 
Ar was added IM solution of SnCU in CH2CI2 (0.24 mL, 0.24 mmol) followed by DDQ (54 
mg, 0.24 mmol) and the resulting mixture was allowed to slowly warm to rt. Then it was 
diluted with ether washed with aqueous NH4CI and brine and dried. Concentration in vacuo 
followed by sgc (15% EtOAc in hexanes) afforded 22e (51 mg, 71%) as a bright orange 
solid; mp 141®C. 'h NMR (CDCI3) 5 3.91 (s. 3 H). 3.97 (s. 3 H). 3.99 (s. 3 H), 6.77 (d, 7 = 9 
Hz. 1 H). 6.93 (s. 1 H). 7.02 (d. 7 = 9 Hz, 1 H). 7.82 (d. 7 = 7 Hz, 1 H), 7.92 (d. 7 = 7 Hz, 1 
H). '^C NMR (CDQa) 5 56.1, 60.9. 61.2, 102.8, 120.2, 121.5, 130.8, 131.8, 133.4, 134.8, 
135.2, 140.4, 143.9, 150.4, 155.8, 184.9, 186.8. IR (neat) cm"' 1680, 1655, 1620. MS m/z 
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(CI) 298 (100%). HRMS m/z (NT) calcd 298.08412, obsrd 298.08411. Anal calcd for 
C,7H,405: C, 68.45; H, 4.73; found: C, 68.39, H, 5.13. 
1,4-Pheiianthreneqiiinone (22a). Cyclization of 20a (77 mg, 0.34 mol) afforded 
22a (52 mg, 74 %) as a light-yellow solid; mp 146®C (lit. 145°C).^ 'H NMR (CDCI3) 5 6.94 
(d, /= 11.4 Hz, 1 H), 6.99 (d, 7 = 11.4 Hz, 1 H), 7.64-7.78 (m, 2 H), 7.89-7.92 (m, 1 H), 8.16 
(d, J = 9.0 Hz, I H), 8.20 (d, 7 = 9.0 Hz, 1 H) 9.54 (d, 7 = 3.3 Hz, 1 H). '^C NMR (CDCI3) 6 
122.0, 127.2, 128.0, 128.8. 130.0, 130.3, 132.3, 135.3, 135.9, 136.6. 140.6. 142.3, 186.1, 
188.4. IR (neat) cm"' 1670, 1660, 1620. 
6-Methoxy-l,4-phenantiirenequmone (22b). Cyclization of 20b (28 mg, 0.11 
mmol) afforded 22b (18 mg, 70%) as an orange solid; rap 192°C (lit. 195°C).^ 'H NMR 
(CDCI3) 6 4.01 (s, 3 H), 6.90 (d, J = 10.2 Hz, 1 H), 6.94 (d, J = 10.2 Hz, 1 H), 7.28 (dd, J = 
2.8,9.0 Hz, 1 H), 7.76 (d, J = 9.0 Hz, 1 H), 8.00 (d, J = 8.4 Hz, 1 H), 8.08 (d, J= 8.4 Hz, 1 H), 
9.02 (d, J = 2.8 Hz, 1 H). '^C NMR (CDQj) 5 55.6, 105.5, 120.0, 121.9, 125.4, 130.2, 132.0, 
132.6, 132.8, 135.0, 135.9, 140.8, 161.6, 186.2, 188.5. IR (neat) cm"' 1660, 1620. 
6,7-Dimethoxy-l,4-phenaiithreneqi]inone (22c). Cyclization of 20c (69 mg, 0.24 
mmol) afforded 22c (44 mg, 68%) as an orange solid; mp 234°C (lit. 236°C).^ 'H NMR 
(CDCI3) 5 4.04 (s, 3 H), 4.10 (s, 3 H), 6.90 (s, 2 H), 7.11 (s, 1 H), 7.97 (d, 7 = 7.5 Hz, 1 H), 
8.02 (d, 7 = 7.5 Hz, 1 H), 9.06 (s, 1 H). '^C NMR (CDa3) 5 56.0, 56.2, 106.1, 106.7, 121.0, 
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125.3, 126.5, 130.8, 133.1, 134.0, 136.1, 140.5, 151.4, 153.2, 186.0, 188.7. IR (neat) cm"' 
1670, 1650, 1620. 
2-(3,43-TrimethoxyphenyI)-l-(3,6-dioxo-l,4-cyclohexadienyl)ethanone (23). To 
a stirred solution of Dess-Martin reagent (848 mg, 2.00 mmol) in CH2CI2 (20 mL) was added 
a solution of 19e (291 mg, 0.91 mmol) in acetonitrile and the resulting solution was allowed 
to stir for 1 h. It was filtered, concentrated and the residue quickly passed through a silica gel 
column (elution with 25% EtOAc in hexanes) to afford 23 (247 mg, 86%) as a red-brown 
unstable semisolid. 'H NMR (CDQa) 5 3.81 (s, 9 H), 4.12 (s, 2 H), 6.36 (s, 2 H), 6.79-6.80 
(m, 2 H), 6.92 (d, 7 = 1.2 Hz, 1 H). 
Bis-10,10'-(5,6,7-trimethoxy-ll-hydroxy-l,4-phenanthrenequinone) (24). To a 
solution of freshly prepared ketoquinone 23 (35 mg, 0.11 mmol) in dry methylene chloride (5 
mL) at -78°C under Ar was added IM solution of SnCLj in CH2CI2 (0.11 mL, 0.11 mmol) 
followed by DDQ (25 mg, 0.11 mmol) and the resulting mixture was allowed to slowly warm 
to rt. It was diluted with ether washed with aqueous NH4CI and brine and dried. 
Concentration followed by sgc (30% EtOAc in hexanes) afforded 24 (15.6 mg, 45%) as a 
dark solid. 'H NMR (CDCI3) 5 3.60 (s, 6 H), 3.91 (s, 6 H), 4.07 (s, 6 H), 6.19 (s, 2 H), 6.85 
(d, / = 9 Hz, 2 H), 7.14 (d, 7 = 9 Hz, 2 H), 11.97 (s, 2 H). NMR (CDCI3) 5 56.1, 61.0, 
61.5, 98.7, 116.3, 117.4, 121.1, 134.4, 135.7, 136.7, 141.2, 141.8, 150.1, 154.1, 157.6, 186.7, 
190.7. IR (neat) cm ' 2942, 1641, 1596. MS m/z (CI): 626 (M^, 32%), 314 (100). HRMS 
m/z (M^ calcd 626.14243, obsrd 626.14371. 
8-Hydroxy-l^^tn]iiethoxybeiiz[a]antiiracene-742-dione (29). To a stirred 
solution of 5,6J-trimethoxy-l,4-phenanthrenequinone (58.4 mg, 0.2 mmol) in dry methylene 
chloride (5 mL) under argon at -78°C was added l-(trimethylsilyloxy)-I.3-butadiene (0.14 
mL, 0.8 mmol) and the resulting solution was allowed to slowly warm to rt. Volatiles were 
removed under reduced pressure, the residue was dissolved in acetone (5 mL) and treated 
with 2.7M solution of Jones reagent (0.163 mL, 0.44 nunol) at 0°C. After 1 h, 10 drops of 
isopropanol were added, the reaction mixture was stirred for an additional 5 min and 
partitioned between chloroform and water. The aqueous layer was extracted with 
chloroform. Combined organic fractions were washed with water and brine and dried over 
MgS04. The solvent was removed and the residue purified by silica gel chromatography 
(elution with 20% ethyl acetate in hexanes) to afford 61 mg (84%) of the title compound as a 
red solid; mp 232°C. X-ray samples were prepared by slow crystallization from hexane-
benzene. 'H NMR (CDCI3) 5 3.98 (s, IH), 4.03 (s, 6H), 6.99 (s, IH), 7.23 (dd, 7 = 1.8, 7.2 
Hz, IH), 7.58-7.66 (m, 2H), 7.90 (d, 7= 8.7 Hz, IH), 8.16 (d, /= 8.7 Hz, IH), 12.24 (s, IH); 
(CDCI3) 6 56.2, 61.1, 61.3, 102.9, 115.6, 118.2, 120.8, 121.5, 122.7, 131.8, 132.1, 135.2, 
136.6, 136.7, 137.1, 143.9, 150.7, 156.2,161.6, 185.9, 188.3. 
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CHAPTERS. STUDIES TOWARD MORPHINE SKELETON 
CONSTRUCTION 
A paper to be submitted to Tetrahedron Letters 
George A. Kraus and Alex Melekhov 
Introduction 
(-)-Morphine (1) (Scheme 1), the main alkaloid of the opium poppy, remains one of 
the most important drugs for the treatment of severe pain. The consumption of this alkaloid 
in the United States is approaching one hundred metric tons annually.' 
Scheme 1 
R'O. 
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2 R^=Me, R^=H codeine 
Morphine is the oldest drug known, with the first documented use going back to 1500 
BC. Now it is commonly used as an analgesic and anesthetic. All of the morphine on the 
today's market is manufacmred from the natural sources by the processing of raw opium 
from Papaver somniferrum. On the large-scale production, both synthetic and biosynthetic 
methods can not compete economically with this method. Namral morphine is used as a 
precursor to other medicinally important compounds such as codeine (2) and thebaine (3). 
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In spite of its small size and long history, it remains an interesting and challenging 
target in organic synthesis. Its molecular framework features three carbocycles (rings A, B 
and C) and two heterocycles (rings D and E) containing five vicinal stereocenters. four of 
which define ring jimctures (Scheme 2). Among those, the benzylic quaternary carbon C13 
creates the biggest challenge. 
Scheme 2 
HO 
HO' 
—N 
OH 
Since the first reported synthesis of morphine more than 40 years ago," there have 
been almost twenty total or formal syntheses, with most of them recently reviewed.^ Still 
neither one of them can compete with isolation procedures. 
In the first synthesis" the formation of quaternary carbon and tricyclic system was 
achieved by Diels-Alder reaction (Scheme 3). The dienophile 5 was prepared in 10 steps 
from 2,6-dihydroxynaphtalene. A chemoselective reduction of 6 with hydrogen-copper 
chromite resulted in cyclization with formation of ketone amide 7. But the lack of 
functionality in the ring C and trans BC ring juncture made further conversions very difficult. 
The synthesis was eventually accomplished in a total of 30 steps. It unambiguously 
established the structure of morphine and defined several important intermediates used in the 
later approaches. 
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Scheme 3 
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A number of efforts followed the biosynthetic pathway. The key step here is the 
oxidative coupling of reticuline (8) to form salutaridine (9). However, it was very difficult to 
achieve since instead of desired ortho-para coupling, mostly sterically favored para-para (10) 
and ortho-ortho (11) products were formed (Scheme 4). The best reported result"* was 23% 
yield when thallium trifluoroacetate was used as an oxidant. 
Scheme 4 
OH 
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Despite the difficulties with regioselectivity this route remains attractive since the 
cyclization of substrates like reticuline proceeds diastereospecifically. Therefore, the 
preparation of 8 as a single enantiomer would result in the enantiomerically pure 
morphinanes. In one of the most original strategies McMurry coupling of the 3-benzyloxy-4-
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methoxybenzaldehyde furnished the stilbene 12/ It was enantioselectively dihydroxyiated 
and converted into the cyclic sulfate 13 (Scheme 5). Treatment of 13 with 
methylaminoacetaldehyde dimethyl acetal followed by acetylation and acidic cyclization 
resulting in the tetrahydroisoquinolene 14. Hydrogenation in the presence of oxalic acid 
yielded (/?)-reticuline as a single enantiomer. 
To avoid the undesired regioselectivity shown earlier (Scheme 4) two possible 
solutions were introduced. One involves blocking of the ortho-position with removable 
groups such as bromine, another uses a synmietrical ring A precursor. The latter found more 
applications especially in the syntheses based on the intramolecular electophilic aromatic 
substitution cyclization. The tricyclic compound 15 was prepared from the corresponding 
tetrahydroisoquinoline by Birch reduction and iV-formylation.^ Upon treatment with sulfuric 
acid it underwent Grewe cyclization^ resulting in formation of morphinane derivative 16 
(Scheme 6). 
Efficient removal of the extra OH group was made possible by selective conversion 
into tetrazole ether 17 followed by hydrogenation to provide thebainone 18. The presence of 
Scheme 5 
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two electron-donating hydroxy groups increases the reactivity of the aromatic ring and 
enhances electrophilic cyclization. 
Scheme 6 
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One other approach to connection of rings A and C is based on the intramolecular 
Heck reaction.® In this method the regioselectivity problem is avoided by the use of 
appropriately substituted precursor. The chiral allylsilane 19, that was prepared in several 
steps from 2-allylcyclohexenone, was reacted with iodoaldehyde 20 (Scheme 7). The 
initially formed imine underwent spontaneous cyclization forming octahydroisoquinoline 21. 
Treatment of 21 with a palladium catalyst resulted in an intramolecular Heck reaction 
furnishing morphinane 22 in 60% yield. It was then converted in four steps into (-)-
dihydrocodeinone 23, that in turn can be converted into morphine in another five steps. 
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The last two cyclization methods are direct and efficient. However, the preparation 
of cyclization precursors 15 and 21 required a nimiber of steps, leaving room for 
improvement. 
Scheme 7 
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Two strategically similar methods involve a tandem formation of rings E and B. In 
the first,' treatment of bromoether 24 with n-BuLi at low temperature leads to a tetracyclic 
compound 25, by the way of an initial lithium-bromine exchange, 1,4-addition of aryllithium 
to a sulfone and intramolecular alkylation of the resulting anion (Scheme 8). However, the 
conversion of 25 to codeinone (4) took ten additional steps due to the difficulties with ring D 
closure. 
An analogous radical cyclization provided a quicker construction of ring system. The 
bromoether 26 was reacted with BusSnH in the presence of AIBN (Scheme 9).'® Tandem 
radical cyclization afforded the tetracyclic amine 27 with unsaturated ring B. Deprotection 
of the amine resulted in a spontaneous cyclization forming dihydroisocodeine 28. 
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Although the radical cascade proceeded in only 35% yield all five rings were 
assembled in only two steps. The preparation of 26 took 9 steps. 
Scheme 9 
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Interestingly, in another approach, the aromatic ring A was formed from the alicyclic 
precursor." The key ring B construction was achieved by a Diels-Alder reaction between 
diene 29 and benzoquinone 30 (Scheme 10). Unfortunately, the attempts to aromatize ring A 
in 31 led to a bridged aminai 32. It took 11 steps to convert 32 into morphinane 33. After 
three more steps 33 was reduced and epimerized forming, thebainone (34). 
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One other unusual approach described the ring B formation from the precursor that 
already featured rings A, C and The aldehyde 35, that was prepared in only 6 steps from 
N-methyl-4-piperidone, was cyclized upon treatment with boron trifluoride etherate to form 
morphinane 36 (Scheme 11). 
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Out of eight approaches described above, five have been developed in the last ten 
years. This is a clear indication of the continuing interest in this area. 
Results and Discussion 
In our approach we wanted to develop a new way for construction of the quaternary 
carbon. The wanted to prepare a cyclization precursor in minimal number of steps from 
easily available materials. Our earlier studies of phenanthrenequinones and existing 
syntheses of morphinanes led us to a key cyclization step based on the electrophilic aromatic 
substitution. To construct the precursor we developed a route that included several quinone 
intermediates. In the retrosynthetic analysis (Scheme 12) we concentrated our attention on 
the two acyl quinone intermediates 38 and 39. We envisioned that Michael addition to 39 
would proceed selectively ortho to the acyl group due to an additional stabilization provided 
by two carbonyl groups.'^ On the other hand, 38 would serve as a key cyclization precursor 
to form the desired quaternary center. Our intention was to prove the possibility of this 
sequence and to develop an efficient route to 37. 
Scheme 12 
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As a source of ring A we chose 3,5-dibenzyloxy-4-methoxyphenylacetaldehyde (40) 
(Scheme 13). The preparation of 40 was partially based on the known methods, and starts 
with inexpensive commercially available methyl gallate (41). Acylation, selective cleavage 
of the para acetoxy group, methylation, deacylation and dibenzylation were done following 
the reported procedure resulting in ester 43 in 91% yield over 4 steps.To convert 43 to the 
desired arylacetaldehyde 40, we first prepared the benzaldehyde 44 in 97% yield by a very 
efficient reduction-oxidation sequence. Treatment of 44 with trimethylsulfonium 
methylsulfate in the presence of a base and rearrangement of the resulting epoxide with 
boron trifluoride dietherate in THF yielded 40 in 86% isolated yield. 
Scheme 13 
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Treatment of 40 with aryllithium 45 derived from hydroquinone,'^ resulted in the 
formation of alcohol 46 (Scheme 14). The reaction proceeded in relatively low yield (56%) 
and our attempts to improve it by using more nucleophilic but less basic organocerium 
reagents did not result in any significant yield change. It was somewhat disappointing since 
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the analogous trimethoxy substituted aldehyde reacted with 45 yielding 74% of the alcohol 
after deprotection.'^ Dess-Martin'® oxidation of the benzylic alcohol in 46, followed by acid-
catalyzed deprotection furnished acyl hydroquinone 47 in 89% jdeld. 
Scheme 14 
CHO 
BnO OBn 
OH xx„ 1) Dess-Martin 
2) KT 
OEE OH 
BnO OBn BnO OBn 
89% 56% OMe OMe 
46 47 
At that point we needed to introduce a substituent ortho to the acyl group of the 
hydroquinone ring. Selective formation of contiguously substimted aromatics is a very 
difficult task. In this case we wanted to exploit the directing effect of carbonyl group in the 
corresponding acylquinone. In our previous work'' these compounds were found to be 
unstable so we decided to optimize the next several transformations on the model system. 
Trimethoxy keto quinone 48 was prepared according to the procedure developed by us.'' We 
expected that Michael addition to 48 would proceed selectively ortho to the acyl group 
because of the combined effiect of two carbonyls. In the first attempt 48 was treated with 
dimethylzinc" at low temperature resulting in regioselective addition forming the desired 
methylated hydroquinone 49 (Scheme 15). Oxidation of 49 with DDQ formed substituted 
quinone SO. 
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We expected quinone 50 to undergo Lewis acid mediated intramolecular cyclization. 
After considerable experimentation we found that treatment of 50 with one equivalent of tin 
tetrachloride at low temperature in methylene chloride followed by slow warming furnished 
the tricyclic triketone 51 and enol 52 in 75% isolated yield (Scheme 16). It was a very 
important result because we were able to form rings A, B and C of the morphine skeleton and 
generate the key quaternary center in one step. 
Scheme 16 
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Now we were ready to use a more sophisticated fiinctional group that would later be a 
source of ring D. This turned out to be a very difficult task. Unstable quinone 53 was first 
prepared by treatment of 47 with DDQ (Scheme 17). Attempt to introduce an allyl group by 
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reacting 53 with allyltributyltin"® resulted in recovery of 47. Eventually we found that 
treatment of 53 with ketene acetal 54"' resulted in ester 55 in 94% yield. The reaction with 
ethyl vinyl ether after acidic hydrolysis yielded lactol 56 in 86% yield (Scheme 17). 
Scheme 17 
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To our disappointment quinone 57 prepared by oxidation of 55 with DDQ did not 
undergo cyclization even at room temperature (Scheme 18). We explained this failure by the 
acidity of methylene alpha to the ester group that facilitated enolization. 
Scheme 18 
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If thai explanation were correct, we would be able to cyclize a substrate without 
acidic protons. Lactol 56 was selectively converted into dithio derivative 59 (Scheme 19). 
Oxidation of 59 with DDQ furnished the quinone 61. After several attempts we worked out 
the optimal conditions for the cyclization. Treatment of 61 with tin tetrachloride at -30°C for 
two hours followed by quenching with saturated aqueous ammonium chloride resulted in the 
formation of desired tricyclic compound 62 in 72% yield. 
Scheme 19 
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This compound has a potential to become a valuable precursor to many substituted 
morphinanes. Cleavage of benzyl groups is expected to result in spontaneous formation of 
hemiacetal, assembling ring E. Deprotection of the aldehyde and reductive amination may 
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lead to the formation of ring D. The substituted ring C may be a source of various morphine 
derivatives for biological activity studies. 
Conclusions 
In this study we developed a straightforward method for the construction of tricyclic 
precursor to morphinanes. Our approach exploited regioselective Michael addition to 
acylbenzoquinones. The key step involved SnCU mediated electrophilic aromatic 
substimtion that led to formation of the quaternary center. The product can be employed in 
the synthesis of ring C substituted morphinanes. 
Experimental 
Unless otherwise noted, materials were obtained from contmiercial suppliers and were 
used without purification. Diethyl ether and tetrahydrofuran (THF) were distilled from 
sodium benzophenone ketyl. Benzene was distilled from lithium aluminum hydride. 
Toluene and methanol were distilled from sodium. Dichloromethane and acetonitrile were 
distilled from calcium hydride. All reactions were conducted under an argon atmosphere and 
all extracts were dried over anhydrous magnesium sulfate. Glassware for experiments 
requiring anhydrous conditions was flame-dried under a stream of argon or in a 150°C oven 
for 12 hours and cooled in dessicator. Silica gel chromatography (sgc) was performed on 
EM Science Kieselgel 60 (mesh 230-400). Thin layer chromatography (tic) was performed 
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using EM Science Kieselgei F2S4 prepared plates with a thickness of 0.25 mm. The solvent 
systems were suitable mixtures of hexanes (H) and ethyl acetate (EA) unless otherwise noted, 
hifirared spectra were obtained on a Perkin-Elmer 1320 spectrophotometer and are reported in 
cm '. Proton nuclear magnetic resonance spectra (300 Mz) were obtained using a Varian 300 
spectrometer. All chemical shifts are reported in 5 relative to the solvent peak and/or 
tetramethylsilane as an internal standart. Splitting patterns are designated as s (singlet), d 
(doublet), t (triplet), q (quartet), dd (doublet of doublets) and m (multiplet); the addition of br 
indicates a broadened pattern. Carbon-13 NMR spectra (75.46 MHz) were obtained on a 
Varian 300 spectrometer and are reported in 5 relative to CDCI3 (77.0 ppm) as an internal 
standard. High-resolution mass spectra (HRMS) were obtained on a Kratos model MS-50 
spectrometer. Low-resolution mass spectra (MS) were obtained on a Finnigan 4023 mass 
spectrometer. The purity of all title compounds was determined to be >95% by 'H NMR 
spectral determination. 
Methyl 3^-<liacetoxy-4-inethoxybeiizoate (42). To a solution of methyl gallate 
(5.15 g, 28 mmol) in acetic anhydride (10.5 mL, 112 mmol) triethylamine (23.4 mL, 168 
mmol) was added slowly at 0°C. After stirring for 5 h at rt (only one spot on TLC), ethanol 
(1.7 mL, 29 mmol) was carefully added at O^C. The reaction mixture was diluted with ethyl 
acetate and washed with water. The organic layer was washed with brine and dried. 
Evaporation of the solvent gave methyl 3,4,5-triacetoxybenzoate (8.5 g, 98% yield) as a 
white solid; mp 129°C (lit."^ 'H NMR (CDCI3) 5 2.30 (s, 9 H), 3.88 (s, 3 H), 7.80 (s, 
2 H). IR (neat) cm"' 3055, 1783, 1733. 
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To a solution of methyl 3,4,5-triacetoxybenzoate (6.2 g, 20 mmol) in DMF (10 mL) 
was added potassium carbonate (8.4 g, 60 mmol) and Mel (2.6 mL, 40 mmol). The resulting 
mixmre was heated at 40°C for 18 h. When the reaction was done (TLC), the mixture was 
filtered and ftltrate diluted with ethyl acetate. The organic phase was washed with water and 
brine, dried and concentrated in vacuo to afford 42 (5.6 g, 99% yield) as a white solid; mp 
82''C (lit.'^ 83°C). 'H NMR (CDCI3) 6 2.34 (s, 6 H), 3.85 (s, 3 H), 3.88 (s, 3 H), 7.69 (s. 2 H). 
NMR (CDCI3) 5 20.8, 52.6, 61.2, 122.8, 125.5, 144.0, 148.5, 165.5, 168.8. IR (neat) cm" 
' 3055, 1775, 1735. 
Methyl 3^-dibenzyloxy-4-methoxybei]zoate (43). To a solution 42 (4.23 g, 15 
mmol) in methanol (60 mL) and water (15 mL) was added potassium carbonate (12.4 g, 90 
mmol). The resulting mixture was stirred for 2 h at room temperature, then concentrated in 
vacuo. The resulting aqueous solution was acidified to pH 2 with IM HCl and extracted with 
ethyl acetate. The organic layer was washed with water and brine, dried and concentrated in 
vacuo to afford methyl 3,5-dihydroxy-4-methoxyben2oate (2.93 g, 98% yield) as a light-
brown solid; mp 145°C 148°C). 'h NMR (CDCI3) 5 3.75 (s, 3 H), 3.85 (s, 3 H), 7.03 (s, 
2 H), 9.40 (br s, 2 H). '^C NMR (CDCI3) 5 52.3, 60.5, 109.9, 126.3, 140.9, 151.4, 168.3. IR 
(neat) cm ' 3545, 1715, 1600. 
To a solution of 3,5-dihydroxy-4-methoxybenzoate (1.98 g, 10 mmol) in dry DMF (5 
mL) was added benzyl bromide (6.84g, 40 mmol), followed by very finely powdered 
potassium carbonate (6.2 g, 45 mmol). The resulting mixture was vigorously stirred under 
argon for 2 days. When the conversion was complete (TLC control), it was filtered and 
filtrate partitioned between chloroform and water. The organic layer was washed three times 
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with water once with brine and dried. Concentration in vacuo gave 43 (3.47 g, 93% yield) as 
a white solid; mp 117®C (lit." I I9°C). 'H NMR (CDQa) 5 3.85 (s, 3 H), 3.91 (s, 3 H), 5.15 
(s, 4 H), 7.18-7.65 (m, 10 H), 7.36 (s, 2 H). "C NMR (CDOj) 5 52.0, 60.8, 71.0, 109.2, 
124.8, 127.2, 127.8, 128.4, 136.5, 143.5. 152.0, 166.4. IR (neat) cm ' 3050, 1700, 1590. 
Methyl 3^-dibeiizyloxy-4-methoxybeiizaldehyde (44). To a solution of 43 (1.89 g, 
5 mmol) in THF (100 mL) at -78®C was added DIBAL-H (IM in hexanes, 10 mL, 10 mmol) 
dropwise over 20 min. The resulting solution was allowed to warm to rt. The excess of 
hydride was carefully neutralized by a dropwise addition of methanol. The resulting mixture 
was diluted with ether and stirred with 0.5M HCl until the precipitate completely dissolved. 
The organic layer was washed with 0.5M HCl, water and brine and dried. After 
concentration in vacuo the resulting product was dissolved in methylene chloride (100 mL) 
and stirred with a mixture of silica gel (5 g) and PCC (3.24 g, 15 mmol). When the oxidation 
was complete (TLC, ca. 1 h) the solvent was removed in vacuo and the residue was dissolved 
in ether (200 mL). The solid was filtered off, and the solution after concentration under 
reduced pressure passed through a short pad of silica gel (20% EtOAc in hexanes). 
Concentration in vacuo afforded 44 (1.67 g, 97% yield) as a white solid; mp 84°C (lit.~ 
85°C). 'h NMR (CDCI3) 6 3.95 (s, 3 H), 5.15 (s, 4 H), 7.12 (s, 2 H), 7.18-7.65 (m, 10 H), 
9.75 (s, 1 H). '^CNMR(CDa3)6 60.9,71.1, 108.9, 127.2, 128.0, 128.4, 131.4, 136.2, 144.9, 
152.7, 190.7. IR (neat) cm"' 3050, 1685, 1580. 
3^-Dibeiizyloxy-4-iiiethoxyphenylacetaldehyde (40). To a solution of 44 (696 mg, 
2 nrniol) in CH2CI2 (5 mL) were added trimethylsulfonium methylsulfate (412 rag, 2.2 
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mmol) and 50% aqueous NaOH (2 mL) and the resulting mixture was vigorously stirred for 2 
h at rt. Water (10 mL) and ether (30 mL) were added and the organic phase separated. The 
aqueous phase was extracted with ether (20 mL), the combined organic fractions were 
washed with water and brine and dried. After removal of the solvents the residue was 
dissolved in dry THF (30 mL) and treated with BF3.Et20 (28 |iL, 0.2 nunol). After 0.5 h the 
solution was diluted with ether, washed with water and brine and dried. Concentration 
followed by sgc purification of the residue (15% EtOAc in hexanes) afforded 40 (622 mg, 
86% yield) as a clear oil. 'H NMR (CDCI3) 5 3.53 (d, / = 2.4 Hz, 2 H), 3.91 (s, 3 H), 5.13 (s, 
4 H), 6.48 (s, 2 H), 7.32-7.46 (m, 10 H), 9.64 (t, /= 1.8 Hz, 1 H). NMR (CDCI3) 5 50.7, 
61.0, 71.3, 109.4, 127.2, 127.4, 128.0, 128.6, 128.7, 137.0, 153.0, 199.2. IR (neat) cm*' 
2950, 1735, 1590. 
2-(3^-Dibeiizyloxy-4-methoxyphenyl)-l-(2^-bis-(l-ethoxyethoxyphenyl))ethanol 
(46). To a stirred solution of l,4-bis-(l-ethoxyethoxy)-benzene (508 mg, 2.0 nmiol) in ether 
(20 mL) at -78®C under Ar was added f-BuLi (1.65M in pentane, 1.1 mL, 1.8 mmol) and the 
resulting solution was stirred for 0.5 h. It was cooled to -78°C, a solution of 40 (543 mg, 1.5 
mmol) in dry THF (5 mL) was added dropwise via a syringe pump and the resulting mixture 
was allowed to slowly warm to rt. Samrated NH4CI was added aqueous layer extracted with 
ether and combined organic fractions were washed with water. After concentration in vacuo, 
the residue was chromatographed (20% EtOAc in hexanes) to afford 46 (517 mg, 56% yield) 
as a clear oil. The isolated 46 is a mixture of several diastereomers. 'h NMR (CDCI3) 5 
1.15-1.48 (m, 12 H), 2.48-3.05 (m, 2 H), 3.45-3.70 (m, 4 H), 3.86-3.89 (m, 3 H), 4.92-5.38 
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(m, 7 H), 6.45-6.47 (m, 2 H), 6.85-7.01 (nu 3 H), 7.24-7.46 (m, 10 H). MS m/z (CI): 617 
(M+lf. 
2<(3^-Dibeiizyloxy-4-methoxyphenyl)-l-(2^-dihydroxyphenyl)ethanone (47). To 
a stirred solution of 46 (493 mg, 0.8 nunol) in methylene chloride (10 mL) were added 
sodium bicarbonate (672 mg, 8 nunol) and pyridine (0.64 mL, 8 mmol) followed by Dess-
Martin reagent (508 mg, 1.5 mmol). The resulting mixture was stirred for 30 min. Aqueous 
sodium thiosulfate (10 mL) was added and stirring continued for 5 more minutes. The 
aqueous layers was extracted with methylene chloride and the combined organic fractions 
were washed in turn wi± 3M aqueous sodium hydroxide and 3M hydrochloric acid. After 
concentration in vacuo the residue was dissolved in 4:1 THF-H2O (25 mL) and treated with 3 
drops of IM H2SO4. After complete deprotection (TLC, ca. 4-6 hrs), ether was added. The 
aqueous layer was extracted with ether and the combined organic fractions were washed with 
water and brine and dried. Removal of the solvent followed by sgc (30% EtOAc in hexanes) 
afforded 47 (334 mg, 89% yield) as a slowly solidifying clear oil; mp 83°C. 'h NMR 
(CDCI3) 8 3.24 (s, 1 H), 3.95 (s, 3 H), 5.07 (s, 4 H), 6.14 (s, 2 H), 6.22 (br s, 1 H), 6.66 (d, J 
= 3.0 Hz, 1 H), 6.88 (d, / = 9.0 Hz, 1 H), 7.07 (dd, J = 3.0, 9.0 Hz, 1 H), 7.25-7.40 (m, 10 H), 
11.57 (s, 1 H). NMR (CDCI3) 5 44.6, 61.3, 70.8, 109.1, 114.3, 118.3, 119.6, 125.6, 
127.3, 128.1, 128.7, 130.2, 136.9, 148.1, 152.7, 156.5, 202.8. IR (neat) cm"' 3100, 1715, 
1590. HRMS: m/z calculated for C31H26O6: 470.1730; measured: 470.1743. 
2-(3^-Dibeiizyloxy-4-methoxyphenyl)-l-(3.6-dioxo-l,4-cycloh«aidienyl)ethanone 
(53). To a stirred solution of 47 (329 mg, 0.7 mmol) in CH2CI2 (10 mL) was added DDQ 
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(159 mg, 0.7 mmol) and the resulting solution was allowed to stir for 1 h. Then it was 
filtered and concentrated in vacuo, affording crude 53 (311 mg, 95% yield) as a red-brown 
unstable semisolid that was used without fiirther purification. 'H NMR (CDCI3) 5 3.87 (s, 3 
H), 4.04 (s, 2 H), 5.09 (s, 4 H), 6.39 (s, 2 H), 6.92 (d, J = 9.9 Hz, 1 H), 6.65-6.72 (m, 2 H), 
7.28-7.43 (m, 10 H). MS m/z (CI): 469 (M+1)^. 
4-((33-Dibenzyloxy-4-methoxyphenyl)acetyl)-2^-dihydroxy-2^-
dihydrobenzofuran (56). To a stirred solution of crude 53 (281 mg, 0.6 nunol) in 
methylene chloride (10 mL) at -78°C was added ethyl vinyl ether (0.29 mL, 3 mmol) and the 
resulting solution was allowed to slowly warm to rt. Volatiles were removed in vacuo and 
the residue was dissolved in 4:1 THF-H2O (25 mL) and treated with 3 drops of trifluoroacetic 
acid. After complete deprotection (TLC, ca. 16-20 hrs), ether was added. The aqueous layer 
was extracted with ether and the combined organic fractions were washed with water and 
brine and dried. Removal of the solvent followed by sgc (30% EtOAc in hexanes) afforded 
56 (277 mg, 86% yield) as a yellow oil. 'h NMR (CDCI3) 5 3.27 (d, J = 16.8 Hz, 1 H), 3.47 
(dd, J = 16.8, 6.3 Hz, 1 H), 3.70 (d, J = 4.8 Hz, 1 H), 3.90 (s, 3 H), 4.01 (s, 2 H), 5.10 (s, 4 
H), 5.95-5.98 (m, 1 H), 6.42 (s, 2 H), 6.84 (d, J = 8.7 Hz, 1 H), 7.03 (d, J = 8.7 Hz, 1 H), 
7.25-7.43 (m, 10 H). NMR (CDCI3) 5 41.6, 48.7, 61.1, 71.2, 100.0, 109.3, 117.4, 118.5, 
118.8, 123.1, 123.5, 127.4, 127.5, 128.0, 128.6, 137.1, 150.8, 152.7, 158.3, 203.5. IR (neat) 
cm ' 3350, 1720, 1636, 1590. HRMS: m/z calculated for C31H28O7: 512.1835; measured: 
512.1848. 
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2-(33-Dibeiizyioxy-4-methoxyphenyl)-l-(2^-dihydroxy-6-((2^-
dithiane)methyI)phenyl)etiianone (59). To a stirred solution of 56 (270 mg, 0.5 nunol) and 
l.3-propanedithioI (50.1 nL, 0.5 nunol) was added ZnQi (IM solution in ether, 1 mL, I 
mmol) and the resulting solution was stirred for 6 h at rt. After disappearance of the starting 
material (TLC), water was added. The aqueous layer was extracted with ether and the 
combined organic fraction washed with brine and dried. Concentration in vacuo followed by 
sgc (gradual elution with 20 to 33% EtOAc in hexanes) afforded 59 (161 mg, 51% yield) as a 
light-yellow oil. 'H NMR (CDCI3) 5 1.78-1.88 (m, 1 H), 1.96-2.06 (m, 1 H), 2.64-2.72 (m, 2 
H), 3.03 (d, J = 7.5 Hz, 2 H), 3.85 (s, 3 H), 4.11 (t, / = 7.5 Hz, 1 H), 4.12 (s, 2 H), 5.06 (s, 4 
H). 5.58 (br s, I H), 6.55 (d, / = 8.7 Hz, 1 H), 6.56 (s, 2 H), 6.67 (br s, 1 H), 6.69 (d, J = 8.7 
Hz. 1 H), 7.25-7.43 (m, 10 H). NMR (CDCI3) 5 25.6, 29.5, 33.4, 46.8, 51.3, 61.1, 71.2, 
109.5, 116.3, 119.8, 123.5, 127.5, 127.6, 127.9, 128.6. 128.8, 129.7, 137.2, 148.1, 148.4, 
152.6, 205.4. IR (neat) cm ' 3300, 3060, 1715, 1595. 
2-(33-Dibeiizyloxy-4-methoxyphenyl)-l-(3,6-dioxo—2-((2^-<lithiane)methyl)-l,4-
cyclohexadienyl)ethanone (61). To a stirred solution of 59 (126 mg, 0.2 nunol) in CHiCli 
(5 mL) at 0°C was added DDQ (45 mg, 0.2 nunol) and the resulting solution was allowed to 
stir for 1 h. Then it was filtered, concentrated in vacuo and passed through a short silica gel 
pad (20% EtOAc in hexanes), affording 61 (118 mg, 94% yield) as an orange-brown oil. 'H 
NMR (CDCI3) 5 1.82-2.05 (m, 2 H), 2.64-2.85 (m, 2 H), 2.82 (d, /= 8.1 Hz, 2 H), 3.88 (s, 3 
H), 3.97 (s, 2 H), 4.01 (t, 7= 8.1 Hz, 1 H), 5.12 (s, 4 H), 6.54 (s, 2 H), 6.71 (d, /= 10.2 Hz, 1 
H), 6.81 (d, / = 10.2 Hz, 1 H), 7.31-7.46 (m, lOH). NMR (CDCI3) 5 25.3, 28.9, 32.3, 
45.0, 51.2, 61.0, 71.2, 109.5, 127.4, 127.7, 128.0, 128.6, 128.8, 135.9, 137.0, 137.1, 141.9, 
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143.7, 152.9, 185.9, 186.1, 200.3. IR (neat) cm"' 3080, 1690, 1675, 1595. HRMS: m/z 
calculated for C34H32O6S2: 600.1640; measured; 600.1646. 
Tricydic enol 62. To a stirred solution of 61 (62.8 mg, 0.1 mmol) in dry methylene 
chloride (5 mL) at -29°C was added tin tetrachloride (IM solution in CHiCb, 0.1 mL, 0.1 
mmol). After 2 h saturated aqueous NH4CI was added at the same temperature and the 
aqueous layer was extracted twice with ether. The combined organic fractions were washed 
with brine and dried. Concentration in vacuo, followed by sgc (20% EtOAc in hexanes) 
afforded 62 (45 mg, 72% yield) as a bright-yellow oil. 'H NMR (CDCI3) 5 1.65-2.02 (m, 2 
H), 2.56-2.73 (m, 5 H), 2.89 (dd, J = 14.1,4.5 Hz, 1 H), 3.53 (dd, J = 9.3,4.5 Hz, 1 H), 3.56 
(d, J = 22.2 Hz, 1 H), 3.83 (s, 3 H), 3.84 (d, J = 22.2 Hz, 1 H), 5.08 (d, 7 = 11.4 Hz, I H), 
5.13 (s, 2 H), 5.39 (d, 7 = 11.4 Hz, 1 H), 6.46 (d, J = 10.2 Hz, 1 H), 6.52 (s, 1 H), 6.61 (d, J = 
10.2 Hz, 1 H), 7.30-7.49 (m, 10 H), 14.50 (s, 1 H). NMR (CDCI3) 5 25.6, 29.9, 30.3, 
44.4, 44.8, 55.3, 61.0, 70.9, 74.1, 108.1, 110.0, 125.8, 126.1, 127.4, 127.5, 127.7, 128.1, 
128.2, 128.3, 128.7, 129.7, 136.7, 137.4, 138.4, 138.6, 141.3, 151.5, 153.0, 198.3. IR (neat) 
cm"' 3050, 1680, 1630. HRMS: m/z calcd for C34H32O6S2: 600.1640; measd; 600.1652. 
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GENERAL CONCXUSIONS 
The task of building complex natural products is often facilitated by the introduction 
of new synthetic methods. In this work we developed direct synthetic approaches to three 
different classes of namral products. In the first chapter we employed PEFA as an oxidant to 
introduce a direct route to pyrrolobenzodiazepines. We also generated acyl radicals by 
oxidative decarboxylation of a-ketoacids. The utility of this methodology was shown in the 
synthesis of 8-deoxy DC-81. In the second chapter we developed a new synthetic approach 
to 1,4-phenanthrenequinones. We also used one phenanthrenequinone for the construction of 
an angularly-fused ring system. In the third chapter we smdied Lewis acid-mediated 
cyclizations of acyl quinones. We synthesized a precursor that may be used in the 
preparation of substimted morphinanes. 
We hope that the new methods developed in this work will find their place in the 
arsenal of synthetic chemists. 
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